Hard cardiovascular diseases

I9_CVD_HARD

cardiovascular disease: A disease involving the cardiovascular system.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints I9_CHD I9_STR	82883
6. Filter based on genotype QC (FinnGen only)	82883

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	I9_CVD_HARD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	I9_CHD\|I9_STR
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hard cardiovascular diseases based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1044716	434042	589344
Only index persons	588925	259263	329662
Unadjusted period prevalence (%)
Whole population	14.91	12.43	16.47
Only index persons	11.24	9.53	12.58
Median age at first event (years)
Whole population	70.01	75.13	66.33
Only index persons	69.38	74.40	65.44

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	82883	28442	54441
Unadjusted period prevalence (%)	19.09	9.69	24.00
Median age at first event (years)	66.71	68.57	65.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15526: Matched controls
131686

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

31.7

323.0

1466

431

XA800

NOMESCO Finland

Neuropsychological investigation

7.7

323.0

1625

1966

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

6.5

323.0

3763

6167

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3174.0

323.0

374

I21.09

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

409

AA1AD

NOMESCO Finland

CT of head and brain

4.7

323.0

5260

12853

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

257.5

323.0

354

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

323.0

3918

16712

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2287.5

323.0

1286

WX872

NOMESCO Finland

Intensive care

7.7

323.0

1284

1518

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

18.6

323.0

918

443

C10AA01

ATC

simvastatin; oral

3.2

323.0

6958

26743

I25

ICD-10 Finland

Chronic ischaemic heart disease

23.1

323.0

919

358

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

323.0

7596

32650

XF400

NOMESCO Finland

ECG with 12 standard connections

4.0

323.0

3304

8328

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

507.8

323.0

466

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.7

323.0

1885

4737

AN4

Balloon angioplasty and drug eluding stent

+∞

323.0

1118

C01DA14

ATC

isosorbide mononitrate; oral

14.3

323.0

2339

1618

AN2

Balloon angioplasty, including several vessels

+∞

323.0

1317

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

247.5

323.0

668

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

323.0

3456

13920

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

21.6

323.0

721

296

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

+∞

323.0

590

C03CA01

ATC

furosemide; systemic

3.3

323.0

3557

10800

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1866.6

323.0

2022

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.3

323.0

3691

11221

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

+∞

323.0

1557

I21.19

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

1524.9

323.0

368

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

17.9

323.0

1448

753

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

5.5

323.0

2375

4170

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3298.4

323.0

388

B01AA03

ATC

warfarin; systemic

4.0

323.0

2453

5875

B01AC24

ATC

ticagrelor; oral

414.3

323.0

1975

I21.11

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

323.0

584

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

10.2

323.0

5406

6546

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

5.6

323.0

4017

7685

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

4.7

323.0

1935

3840

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

6.1

323.0

1003

1462

XF402

NOMESCO Finland

ECG with work load test

3.5

323.0

2117

5749

C10AA05

ATC

atorvastatin; oral

5.6

323.0

8782

24946

C10AX09

ATC

ezetimibe; oral

7.1

323.0

3274

4792

I50.9

ICD-10 Finland

Heart failure, unspecified

5.6

323.0

1291

2085

C08CA01

ATC

amlodipine; oral

2.5

323.0

5463

23236

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

880.7

323.0

503

I20.99

ICD-10 Finland

Angina pectoris, unspecified

8.0

323.0

1060

1191

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

+∞

323.0

1202

R07.4

ICD-10 Finland

Chest pain, unspecified

3.5

323.0

5644

18698

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

6.9

323.0

1024

1342

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

1100.3

323.0

380

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

88.9

323.0

1019

104

K90

ICPC

Stroke/cerebrovascular accident

40.2

323.0

746

165

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

5.6

323.0

1460

2393

I21.01

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

323.0

678

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

52.6

323.0

2314

437

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

43.9

323.0

4995

1407

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

41.2

323.0

833

181

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

5735.8

323.0

657

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

+∞

323.0

901

C07AB07

ATC

bisoprolol; oral

4.4

323.0

9088

31783

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

323.0

9065

45412

AN1

Coronary angiography

16.8

323.0

3104

1928

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

15.0

323.0

1259

768

I25.1

ICD-10 Finland

Atherosclerotic heart disease

22.1

323.0

5526

3214

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

756.1

323.0

4652

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

9.5

323.0

1944

1953

I20.01

ICD-10 Finland

Unstable angina

415.0

323.0

793

AN3

Balloon angioplasty and metallic stent

+∞

323.0

663

Angiography of the heart and coronary arteries

10.7

323.0

675

555

B01AC04

ATC

clopidogrel; oral

23.6

323.0

5050

2636

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.6

323.0

2707

4821

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

+∞

323.0

888

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

8.4

323.0

1036

1114

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

1354.7

323.0

455

I20.09

ICD-10 Finland

Unstable angina

142.6

323.0

2147

148

R4110

NOMESCO Finland

Physiotherapy

2.3

323.0

4694

21202

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

3700.1

323.0

433

I25.2

ICD-10 Finland

Old myocardial infarction

175.4

323.0

1663

I20.00

ICD-10 Finland

Unstable angina

203.7

323.0

798

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

11.3

323.0

904

717

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

11.1

323.0

1092

888

205

Kela drug reimbursment

Chronic hypertension

2.4

323.0

3456

13844

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

16.4

323.0

6974

6255

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

36.1

323.0

2252

615

C09AA05

ATC

ramipril; oral

5.0

323.0

5122

11707

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

16384.0

323.0

1741

R4120

NOMESCO Finland

Occupational therapy

4.3

323.0

1590

3389

C10AA07

ATC

rosuvastatin; oral

2.7

323.0

4607

17767

WX892

NOMESCO Finland

Monitored bed care

5.2

323.0

1718

3060

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.5

323.0

4623

11239

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

319.9

2750

9999

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.3

310.1

3799

16569

K76

ICPC

Ischaemic heart dis without angina

26.3

304.6

450

149

A02BC02

ATC

pantoprazole; systemic

1.9

304.6

10229

66078

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

13.0

297.5

563

379

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

+∞

297.1

303

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

290.9

3119

12693

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

56.4

289.5

364

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

+∞

283.3

289

I63.8

ICD-10 Finland

Other cerebral infarction

191.6

280.6

310

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.9

277.3

1986

6416

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

276.6

1675

4830

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

+∞

269.6

275

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

268.3

3703

16864

Single vessel balloon catheter extension

+∞

266.6

272

XF404

NOMESCO Finland

Ambulatory ECG

3.2

265.9

1562

4399

R42

ICD-10 Finland

Dizziness and giddiness

2.3

263.5

3108

13168

N02AX02

ATC

tramadol; systemic, rectal

1.8

262.6

6710

38556

R06.0

ICD-10 Finland

Dyspnoea

2.1

260.9

3575

16198

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.6

257.4

1318

3335

C07AB02

ATC

metoprolol; systemic

2.4

257.3

2586

10111

R4150

NOMESCO Finland

Neuropsychological rehabilitation

17.4

252.9

425

212

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

30.7

252.4

358

101

I21.00

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

250.9

256

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.2

249.7

1488

4223

A10AE04

ATC

insulin glargine; parenteral

3.1

249.6

1579

4676

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.6

248.2

698

939

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.4

247.9

1374

3696

AA1

Conventional CABG

+∞

246.9

252

N02BE01

ATC

paracetamol; systemic, rectal

2.1

246.5

13193

96297

I50.0

ICD-10 Finland

Congestive heart failure

7.6

242.5

614

709

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.8

241.0

1131

2656

A10BA02

ATC

metformin; oral

2.0

233.4

3656

17389

N18

ICPC

Paralysis/weakness

12.7

232.6

444

304

C03DA01

ATC

spironolactone; oral

3.1

228.3

1420

4144

207

Kela drug reimbursment

Chronic arrhythmias

3.2

226.6

1372

3928

280

Kela drug reimbursment

Clopidogrel

179.5

225.3

250

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

+∞

222.4

227

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.3

221.7

1275

3513

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.5

221.6

1164

2994

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

7.6

221.1

559

643

I50.1

ICD-10 Finland

Left ventricular failure

7.5

220.7

561

651

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.9

217.0

1530

4847

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

85.2

216.5

257

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

8.5

215.8

508

521

T90

ICPC

Diabetes non-insulin dependent

2.1

215.0

3167

14620

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

7.0

213.1

568

707

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.3

212.5

1180

3165

AA5PD

NOMESCO Finland

CT examination of brain pefusion

25.9

209.8

311

104

I20.90

ICD-10 Finland

Angina pectoris, unspecified

8.8

207.8

479

474

R51.80

ICD-10 Finland

Headache

2.2

205.7

2478

10461

RD211

NOMESCO Finland

3.7

203.5

975

2321

TKC20

NOMESCO Finland

Catheterisation of bladder

3.7

203.3

972

2310

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.7

200.6

630

975

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

888.7

198.5

207

K91

ICPC

Cerebrovascular disease

24.6

197.0

296

104

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

+∞

195.9

200

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.7

193.7

1529

5174

N02AA05

ATC

oxycodone; systemic

2.4

193.0

1862

7039

I21.10

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

+∞

192.9

197

SPAT1262

SPAT

Handing over of treatment supplies

2.1

191.8

2508

10946

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

25.4

191.3

285

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

853.9

190.7

199

A28

ICPC

Limited function/disability NOS

2.7

188.0

1453

4851

FN2CA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure

25.8

187.5

278

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

13.9

187.0

343

214

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

6.3

185.0

531

732

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

184.9

2632

11886

A11

ICPC

Chest pain NOS

3.0

183.3

1169

3448

R07.3

ICD-10 Finland

Other chest pain

2.6

181.6

1530

5365

K84

ICPC

Heart disease other

8.3

181.6

434

456

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

5.0

179.5

630

1108

201

Kela drug reimbursment

Chronic cardiac insufficiency

5.8

179.5

555

842

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.7

177.7

868

2095

N03AX12

ATC

gabapentin; oral

2.0

175.7

2548

11571

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

57.0

174.7

219

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

173.8

1062

3039

SPAT1216

SPAT

Assessment of functional ability

2.3

170.8

1768

6898

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

169.5

3941

21161

A10AE05

ATC

insulin detemir; parenteral

3.3

169.2

933

2477

H53.4

ICD-10 Finland

Visual field defects

6.6

167.9

467

616

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.8

167.8

1242

4027

N03AX16

ATC

pregabalin; oral

1.8

165.0

3725

19782

C10AA03

ATC

pravastatin; oral

3.3

164.9

911

2421

B01AB05

ATC

enoxaparin; parenteral

1.7

163.6

4163

22942

C09CA01

ATC

losartan; oral

1.8

159.9

3323

17150

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

158.8

3993

21889

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

158.8

1472

5416

Z71.8

ICD-10 Finland

Other specified counselling

1.8

156.9

3482

18340

C09AA02

ATC

enalapril; systemic

2.0

156.3

2315

10550

C10AA04

ATC

fluvastatin; oral

3.0

155.1

977

2848

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

5.9

154.9

469

692

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

152.6

2421

11322

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

151.8

913

2578

I63

ICD-10 Finland

Cerebral infarction

56.2

151.3

190

R1260

NOMESCO Finland

Evaluation of communicative skills

9.2

151.0

339

320

SPAT1097

SPAT

Recording of ECG

2.1

150.9

1931

8272

I21.4

ICD-10 Finland

Acute subendocardial myocardial infarction

159.0

149.3

167

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

4.1

148.7

628

1330

R53

ICD-10 Finland

Malaise and fatigue

1.9

147.3

2563

12390

FL1AC

NOMESCO Finland

Left cardioangiography

12.9

147.1

278

186

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.7

146.2

693

1626

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.3

146.0

1593

6344

L28

ICPC

Limited function/disability (L)

2.1

145.1

1796

7575

I21.39

ICD-10 Finland

Acute transmural myocardial infarction with unspecified localization unspecified coronary artery status

1312.5

144.7

150

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

144.2

1172

4004

PA7BD

NOMESCO Finland

CT angiography of neck and brain

7.3

144.0

372

441

SPAT1254

SPAT

Administration of medicine

2.2

141.1

1673

6917

A10AA02

ATC

4.0

140.9

619

1359

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.5

139.9

544

1063

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

139.6

1662

6882

M79.6

ICD-10 Finland

Pain in limb

1.6

139.1

5205

31604

S18

ICPC

Laceration/cut

1.6

139.1

5568

34389

I21.21

ICD-10 Finland

Acute transmural myocardial infarction with another location stenosed coronary artery

619.5

138.0

145

C08CA13

ATC

lercanidipine; oral

2.2

137.1

1671

6989

AP1

Catheterization of the left side of the heart

11.7

137.0

270

198

G81.9

ICD-10 Finland

Hemiplegia, unspecified

9.4

136.8

303

279

K74

ICPC

Ischaemic heart dis with angina

20.3

135.3

215

B01AC07

ATC

dipyridamole; systemic

9.9

135.2

290

252

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

134.4

5685

35502

B01AF02

ATC

apixaban; oral

2.8

133.9

932

2895

A10AA01

ATC

4.0

133.8

590

1299

FNE20

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery

+∞

131.1

134

N03AX14

ATC

levetiracetam; systemic

4.4

130.7

518

1031

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

9.6

130.1

284

255

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

130.0

3869

22028

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

7.7

129.6

322

360

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

128.6

1139

4072

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

127.0

5205

32133

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

11.1

126.3

256

199

TK800

NOMESCO Finland

Hemodialysis

5.0

126.1

438

760

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

124.5

1401

5640

R4130

NOMESCO Finland

Speech therapy

5.1

123.7

419

707

Z50.0

ICD-10 Finland

Cardiac rehabilitation

21.7

123.5

192

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

44.5

123.3

161

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

121.6

3830

22062

ZX120

NOMESCO Finland

Intravenous

2.2

121.6

1403

5709

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.4

120.6

389

620

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.9

120.6

805

2432

FN1CA

NOMESCO Finland

Optical coherence tomography of coronary arteries

31.5

120.3

169

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

10.1

120.2

255

217

R55

ICD-10 Finland

Syncope and collapse

2.3

119.9

1208

4610

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

119.6

783

2336

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

118.6

5891

37851

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.4

118.1

463

912

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.5

117.8

451

867

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.5

117.6

274

276

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

4.5

117.4

452

874

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

8.8

116.9

267

260

SPAT1301

SPAT

No procedures

1.6

116.3

3822

22214

FN2AA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), balloon only

49.0

116.2

149

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.2

115.3

387

646

H3603, E103

ICD-10 Finland

6.8

115.3

311

393

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.0

114.8

503

1100

R11

ICD-10 Finland

Nausea and vomiting

2.4

113.9

1056

3860

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.7

113.6

534

1242

A10BK03

ATC

empagliflozin; oral

2.3

113.0

1124

4257

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

112.0

1390

5830

XF620

NOMESCO Finland

Examination of circulation with color method

14.2

111.8

202

122

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

502.9

111.7

118

SPAT1263

SPAT

Sampling

1.5

111.6

5447

34723

I25.8

ICD-10 Finland

Other forms of chronic ischaemic heart disease

37.5

110.4

149

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

110.0

3712

21668

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.5

109.4

558

1388

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

109.0

974

3489

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

108.9

977

3507

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.0

108.2

377

656

SPAT1310

SPAT

Counselling related to known health issue

1.6

107.4

4069

24413

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.3

107.1

598

1594

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.5

107.0

542

1340

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.6

107.0

880

3010

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.0

107.0

677

1972

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.4

106.9

302

407

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

106.7

1758

8243

N06AX11

ATC

mirtazapine; oral

1.5

106.5

4610

28526

I20.0

ICD-10 Finland

Unstable angina

23.4

106.1

161

C08CA02

ATC

felodipine; oral

2.4

105.7

956

3446

R02

ICPC

Shortness of breath/dyspnoea

2.0

105.5

1461

6407

315

Kela drug reimbursment

Clopidogrel

23.9

105.4

159

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

105.2

2020

9991

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

22.6

105.0

161

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

105.0

2065

10292

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

104.4

1176

4718

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

104.1

1909

9294

I20.91

ICD-10 Finland

Angina pectoris, unspecified

21.9

104.0

161

B01AC22

ATC

prasugrel; oral

67.4

103.3

126

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

103.1

1292

5434

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

103.0

1085

4217

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

102.5

1244

5160

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

102.1

1554

7069

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

9.5

101.8

223

202

I21.29

ICD-10 Finland

Acute transmural myocardial infarction with other localization unspecified coronary artery status

+∞

101.7

104

J01FF01

ATC

clindamycin; systemic

1.5

101.7

3965

23892

FN1XT

NOMESCO Finland

Other coronary artery procedure through catheter

66.3

101.4

124

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

8.2

99.7

238

250

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

99.5

3004

16962

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

99.3

1491

6744

C02AC05

ATC

moxonidine; oral

3.1

99.1

586

1626

EBA00

NOMESCO Finland

Extraction of tooth

1.5

99.0

4525

28239

N19

ICPC

Speech disorder

9.2

98.8

220

205

Coronary artery bypass surgery

+∞

98.8

101

S97

ICPC

Chronic ulcer skin

3.0

98.4

619

1795

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

98.2

1832

8957

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

3.7

98.0

468

1103

H02AB06

ATC

prednisolone; systemic

1.4

97.8

6402

43013

T89

ICPC

Diabetes insulin dependent

2.8

96.7

666

2047

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

96.3

827

2896

SPAT1252

SPAT

Overall medication plan or its review

2.5

96.2

817

2843

R47.0

ICD-10 Finland

Dysphasia and aphasia

12.0

95.7

186

133

A10BH01

ATC

sitagliptin; oral

2.2

95.3

1132

4645

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

4.2

95.2

387

789

A10BB12

ATC

glimepiride; oral

3.0

95.0

612

1802

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

4.5

94.9

366

709

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

10.4

94.7

197

162

I20

ICD-10 Finland

Angina pectoris

8.7

94.0

216

213

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

93.8

4802

30616

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

93.6

6840

46800

N03AF02

ATC

oxcarbazepine; oral

3.2

93.4

536

1457

M04AA01

ATC

allopurinol; systemic

2.2

93.2

1099

4492

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

17.8

93.1

154

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

17.8

93.1

154

K78

ICPC

Atrial fibrillation/flutter

3.1

92.1

544

1510

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

5.5

91.9

293

461

C03AA03

ATC

hydrochlorothiazide; oral

2.1

91.2

1121

4668

FN2EC

NOMESCO Finland

Transcatheter coronary thrombectomy

809.7

91.0

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

24.2

90.7

136

N05CF01

ATC

zopiclone; oral

1.5

90.4

4232

26427

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

11.1

90.2

182

141

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.2

90.1

522

1427

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.0

89.7

264

376

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

10.8

89.6

183

145

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

66.5

89.3

109

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.6

88.3

328

612

I35.0

ICD-10 Finland

Aortic (valve) stenosis

3.8

88.2

410

944

R04.0

ICD-10 Finland

Epistaxis

2.5

87.1

750

2626

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

87.0

2303

12499

AAF00

NOMESCO Finland

Ventriculostomy

10.7

86.6

178

143

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

86.3

4124

25813

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

4.7

86.1

313

571

A46

ICD-10 Finland

Erysipelas

1.8

86.0

1611

7860

SPAT1229

SPAT

Assessment of need for aid

2.3

86.0

867

3291

WZC30

NOMESCO Finland

Teaching

1.8

85.8

1827

9293

WX002

NOMESCO Finland

Sedation and analgesia

1.6

85.7

2514

14019

C08DB01

ATC

diltiazem; oral

3.5

85.5

430

1057

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

85.2

558

1661

R50.9

ICD-10 Finland

Fever, unspecified

1.8

84.9

1702

8492

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

84.5

2096

11156

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.9

83.7

369

811

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

83.7

900

3524

XCK00

NOMESCO Finland

Perimetry

2.3

83.7

857

3279

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.9

83.5

292

511

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

83.2

899

3529

FXZ00

NOMESCO Finland

Off-pump cardiac operation

52.7

83.1

105

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

82.6

1592

7837

WX110

NOMESCO Finland

Local anesthesy

1.4

82.1

10110

75187

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

81.9

2331

12880

R03BB04

ATC

tiotropium bromide; inhalant

2.1

81.6

1063

4526

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

81.4

1785

9155

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

9.2

81.4

181

169

PA6AD

NOMESCO Finland

CT of neck arteries

6.6

80.7

222

289

SPAT1153

SPAT

Removal of sutures

1.5

79.8

3933

24695

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

8.0

79.7

192

205

G44.2

ICD-10 Finland

Tension-type headache

1.7

79.1

1893

9958

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

6.2

78.5

226

313

SPAT1260

SPAT

Consultation of another employee

1.6

78.3

2147

11730

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

78.1

401

1002

FN2CB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion

17.8

78.1

129

N18.8

ICD-10 Finland

Other chronic renal failure

4.4

78.1

305

599

R60.0

ICD-10 Finland

Localized oedema

1.9

77.9

1231

5650

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

77.6

760

2843

C09CA06

ATC

candesartan; oral

1.5

77.5

2965

17596

C01AA05

ATC

digoxin; systemic

3.5

77.5

390

959

A06AD11

ATC

lactulose; oral

1.9

77.2

1355

6457

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.4

77.1

397

994

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

12.1

76.6

148

105

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.9

75.7

263

457

L17

ICPC

Foot/toe symptom/complaint

1.5

75.6

3092

18617

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

2.4

75.3

672

2397

L04AA06

ATC

mycophenolic acid; systemic

3.6

75.1

361

855

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.9

75.1

200

249

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

74.5

937

3927

K22

ICPC

Risk factor cardiovascular disease

2.5

74.0

640

2244

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.0

73.9

997

4303

A11CC03

ATC

alfacalcidol; systemic

3.7

73.7

343

791

Z00.0

ICD-10 Finland

General medical examination

1.6

73.6

2246

12601

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

3.8

73.6

333

750

C07AG02

ATC

carvedilol; oral

2.5

73.5

612

2102

RS221

NOMESCO Finland

4.2

73.5

300

615

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

12.8

73.5

138

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

91.7

73.4

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.1

73.3

247

415

FNC40

NOMESCO Finland

Aorto-coronary venous bypass with four distal anastomoses

+∞

73.3

WX730

NOMESCO Finland

Conventional respirator

4.9

73.2

258

456

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

4.7

73.1

266

486

UJF32

NOMESCO Finland

Coloscopy

1.5

73.0

3175

19349

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.4

72.9

386

988

J01DB01

ATC

cefalexin; oral

1.4

72.9

12004

92794

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

72.7

1368

6668

ZXA05

NOMESCO Finland

Left side

1.5

72.5

3179

19406

N06AA09

ATC

amitriptyline; systemic

1.8

72.0

1444

7183

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

13.2

71.8

133

FNE21

NOMESCO Finland

Coronary bypass using free arterial graft of radial artery sequential

+∞

71.4

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

+∞

71.4

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

71.2

784

3101

SPAT1104

SPAT

Monitoring of emergency patient

2.2

71.2

802

3203

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.4

70.9

198

264

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

5.1

70.7

240

407

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

70.4

958

4145

FNA20

NOMESCO Finland

Anastomosis to coronary arteries from bilateral internal mammary arteries

+∞

70.4

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

70.4

1627

8452

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.7

70.1

529

1718

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.1

70.1

235

393

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

70.0

2183

12304

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.1

70.0

237

401

127

Kela drug reimbursment

Transplant complication

3.8

69.4

319

728

N06AB04

ATC

citalopram; systemic

1.5

69.4

3038

18511

N05BA01

ATC

diazepam; systemic, rectal

1.6

69.4

1837

9913

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

69.3

775

3083

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.1

69.3

291

613

C01BD01

ATC

amiodarone; systemic

3.9

68.7

304

671

G47.3

ICD-10 Finland

Sleep apnoea

1.5

68.7

3125

19190

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

68.5

1022

4582

H53.2

ICD-10 Finland

Diplopia

3.0

68.3

427

1232

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

8.2

68.1

162

170

NHQ40

NOMESCO Finland

Amputation of toe

6.2

68.1

195

269

ANB

Coronary thrombectomy

+∞

67.5

M10.9

ICD-10 Finland

Gout, unspecified

2.6

67.4

545

1842

ZXA00

NOMESCO Finland

Right side

1.5

67.3

3384

21201

SPAT1255

SPAT

Intravenous administration of medicine

2.1

67.2

797

3255

R03AC02

ATC

salbutamol; inhalant

1.3

67.1

7420

53295

WX882

NOMESCO Finland

High dependency care

3.3

67.0

364

950

N05BA04

ATC

oxazepam; oral

1.5

66.2

3244

20203

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

5.3

65.9

215

349

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

65.7

2377

13864

FN2CC

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of left main trunk

23.5

65.6

FNG10

NOMESCO Finland

Embolectomy of coronary artery

+∞

65.5

A04

ICPC

Weakness/tiredness general

1.8

65.2

1276

6288

I21

ICD-10 Finland

Acute myocardial infarction

106.5

65.1

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.3

65.0

348

899

R07.2

ICD-10 Finland

Precordial pain

3.6

64.8

317

763

ANE

Coronary internal ultrasound (IVUS)

201.6

64.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

64.7

338

857

A12AA04

ATC

calcium carbonate; oral

4.4

64.6

251

491

TFP20

NOMESCO Finland

Cardiodefibrillation

2.3

64.5

645

2434

A02BC01

ATC

omeprazole; systemic

1.4

64.2

3365

21220

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.6

64.1

236

437

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.1

63.8

370

1013

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

63.2

1395

7133

C09CA03

ATC

valsartan; oral

1.9

63.2

1058

4944

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

63.0

783

3263

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

63.0

4340

28761

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

195.9

62.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

62.8

1197

5847

I20.10

ICD-10 Finland

Angina angiospastic

17.9

62.7

103

J01MA12

ATC

levofloxacin; systemic

1.6

62.7

2139

12289

I21.0

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

62.6

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

62.4

1536

8105

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

62.4

330

845

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.9

62.0

978

4473

C09AA04

ATC

perindopril; oral

2.4

61.7

584

2146

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

61.3

699

2804

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

61.1

451

1445

N18.0

ICD-10 Finland

End-stage renal disease

5.6

61.0

188

285

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.3

60.5

324

837

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

60.5

696

2801

R47.1

ICD-10 Finland

Dysarthria and anarthria

8.3

60.3

142

147

M54.5

ICD-10 Finland

Low back pain

1.4

60.2

4502

30200

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

60.1

253

535

N03AF01

ATC

carbamazepine; oral, rectal

2.1

60.1

703

2854

C08CA05

ATC

nifedipine; systemic

2.3

59.6

619

2378

I42.0

ICD-10 Finland

Dilated cardiomyopathy

3.3

59.5

323

843

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

59.4

1383

7177

I21.91

ICD-10 Finland

Myocardial infarction (acute) UNS stenosed coronary artery

270.4

59.3

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

18.6

59.3

H3603, E113

ICD-10 Finland

7.2

59.0

152

181

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

19.6

59.0

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

5.3

58.6

191

310

SPAT1053

SPAT

Memory test

2.0

58.6

805

3493

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

58.0

790

3414

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

58.0

1345

6971

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

57.8

2145

12545

3015

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

24.4

57.8

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

10.5

57.8

119

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

57.6

1544

8334

V03AE01

ATC

polystyrene sulfonate; oral

5.8

57.6

174

258

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

57.5

2113

12328

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

57.4

230

464

SPAT1240

SPAT

Therapeutic discussion

1.7

57.4

1385

7259

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

57.3

1167

5813

A02BC05

ATC

esomeprazole; systemic

1.3

57.2

5669

39681

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

2.7

57.1

419

1337

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.9

56.9

168

242

A10AE06

ATC

insulin degludec; parenteral

2.6

56.6

459

1553

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

93.7

56.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.9

56.6

373

1115

M48.0

ICD-10 Finland

Spinal stenosis

1.7

56.5

1214

6151

I47.2

ICD-10 Finland

Ventricular tachycardia

3.9

56.4

245

533

294

Kela drug reimbursment

Alirocumab and evolocumab for the treatment of hypercholesterolaemia and dyslipidaemia

30.6

56.3

S06.0

ICD-10 Finland

Concussion

1.7

56.1

1220

6202

PE1AT

NOMESCO Finland

Femoral artery PTA

9.1

55.9

124

116

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.2

55.7

185

307

K08.3

ICD-10 Finland

Retained dental root

1.9

55.6

903

4170

K01

ICPC

Heart pain

5.8

55.6

167

246

J01MA02

ATC

ciprofloxacin; systemic

1.3

55.4

4702

32089

-1

NOMESCO Finland

1.3

54.9

4549

30923

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.8

54.9

251

572

FFC42

NOMESCO Finland

Percutaneous closure of patent foramen ovale

63.5

54.8

137

Kela drug reimbursment

Uraemia requiring dialysis

5.5

54.8

173

271

AA2

Off pump CABG sternotomy

+∞

54.7

43609

ICD-8 Finland

+∞

54.7

FNA02

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, two distal anastamoses

+∞

54.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

54.7

3541

23099

N17

ICPC

Vertigo/dizziness

1.8

54.6

1107

5506

I42.8

ICD-10 Finland

Other cardiomyopathies

8.8

54.5

123

119

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

54.3

1243

6414

TAB00

NOMESCO Finland

Lumbar puncture

2.1

54.3

651

2667

A12BA01

ATC

potassium chloride; oral

3.2

54.3

307

826

K99

ICPC

Cardiovascular disease other

3.5

54.2

268

651

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

54.2

362

1090

B01AC06

ATC

acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)

23.8

54.1

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

54.0

4034

26948

A02BA02

ATC

ranitidine; systemic

1.5

53.8

2360

14287

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

+∞

53.8

K85

ICPC

Elevated blood pressure

1.6

53.7

1543

8470

K29

ICPC

Cardiovascular sympt/complt other

2.6

53.6

433

1461

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

53.4

493

1789

C09BA02

ATC

enalapril and diuretics; systemic

2.0

53.2

784

3492

H3601, E103

ICD-10 Finland

4.4

53.2

203

391

Z72.0

ICD-10 Finland

Tobacco use

2.6

53.2

414

1369

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

53.0

2425

14808

N03AG01

ATC

valproic acid; systemic, rectal

1.9

52.9

865

4005

J01FA06

ATC

roxithromycin; oral

1.3

52.9

5654

39883

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.0

52.8

227

490

N06AX21

ATC

duloxetine; oral

1.6

52.6

1576

8744

Catheterization and pressure measurement of the left side of the heart

9.2

52.5

116

108

K89

ICPC

Transient cerebral ischaemia

7.3

52.3

133

156

H36.01

ICD-10 Finland

Diabetic maculopathy

4.8

52.2

185

330

N05AH04

ATC

quetiapine; oral

1.5

52.2

2142

12783

H3601, E113

ICD-10 Finland

5.1

52.1

176

298

ZXA10

NOMESCO Finland

Bilateral

1.5

51.8

2037

12043

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.5

51.7

143

189

A02BC03

ATC

lansoprazole; oral

1.4

51.7

3820

25436

PA2AD

NOMESCO Finland

CT angiography of brain

7.8

51.6

125

136

J01DA01

ATC

[U] cefalexin; systemic

1.3

51.6

8790

66044

H04AA01

ATC

glucagon; nasal, parenteral

2.8

51.4

349

1062

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

51.3

902

4278

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

51.3

331

975

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

51.2

350

1071

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

6.4

51.2

143

192

K02

ICPC

Pressure/tightness of heart

3.2

51.1

292

793

PD5AD

NOMESCO Finland

CT of aorta

5.1

50.7

170

286

P20

ICPC

Memory disturbance

2.0

50.6

677

2903

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.2

50.6

204

415

I50

ICD-10 Finland

Heart failure

5.3

50.5

163

262

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.1

50.4

210

441

N03AB02

ATC

phenytoin; systemic

5.0

50.4

170

288

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.2

50.2

205

422

A01

ICPC

Pain general/multiple sites

1.8

50.2

876

4146

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

50.2

546

2143

WX402

NOMESCO Finland

General anaesthesia

1.5

50.0

2236

13572

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

49.8

1144

5899

N05CD07

ATC

temazepam; oral

1.6

49.7

1342

7243

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.3

49.7

265

684

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.9

49.5

314

916

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

49.4

771

3508

N30.0

ICD-10 Finland

Acute cystitis

1.6

49.4

1474

8161

H3600, E103

ICD-10 Finland

3.9

49.3

219

487

I20.9

ICD-10 Finland

Angina pectoris, unspecified

7.1

49.3

128

155

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

48.8

764

3480

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.7

48.7

359

1151

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

48.7

954

4690

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

48.5

1388

7602

V03AE02

ATC

sevelamer; oral

7.5

48.5

121

138

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

48.5

4896

34125

K92

ICPC

Atherosclerosis/periph vascular dis

6.3

48.4

136

184

PA2YT

NOMESCO Finland

Cerebral artery PTA with stent

12.3

48.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.2

48.3

550

2203

K75

ICPC

Acute myocardial infarction

62.9

48.2

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

48.2

564

2289

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.8

47.9

168

297

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

6.9

47.8

126

156

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.4

47.8

248

627

SPAT1234

SPAT

Support of social functional capacity

2.4

47.5

432

1555

CKC15

NOMESCO Finland

Panretinal photocoagulation

6.4

47.3

132

177

C02EA02

ATC

3.2

47.3

267

717

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

47.3

991

4974

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

47.1

223

524

L03

ICPC

Low back symptom/complaint

1.4

47.0

2952

19076

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

217.3

46.8

N28

ICPC

Limited function/disability (N)

4.2

46.8

188

382

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

46.7

1403

7779

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

46.6

563

2313

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

46.5

345

1110

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

46.3

8162

61171

I51.4

ICD-10 Finland

Myocarditis, unspecified

6.1

46.3

134

189

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.0

46.3

281

795

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.8

46.2

327

1022

A10BH05

ATC

linagliptin; oral

2.5

46.1

374

1267

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

45.9

465

1766

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

8.4

45.9

106

107

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.9

45.9

202

446

N01

ICPC

Headache

1.7

45.8

1108

5798

SPAT1325

SPAT

Vaccination

1.4

45.8

3242

21363

Z49.2

ICD-10 Finland

Other dialysis

5.6

45.7

140

212

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.2

45.6

261

710

E87.5

ICD-10 Finland

Hyperkalaemia

4.9

45.6

158

276

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.2

45.5

183

372

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

45.5

532

2156

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.8

45.3

207

472

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

45.3

311

956

K92.1

ICD-10 Finland

Melaena

2.3

45.3

434

1606

R52.2

ICD-10 Finland

Other chronic pain

2.3

45.2

459

1745

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

9.4

45.1

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

7.2

45.1

115

136

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

44.9

683

3074

SPAT1360

SPAT

Extensive global examination

1.8

44.9

775

3649

RS222

NOMESCO Finland

4.2

44.9

183

377

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.2

44.8

254

686

B01AF01

ATC

rivaroxaban; oral

1.6

44.8

1152

6131

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.8

44.8

157

278

C09DX04

ATC

valsartan and sacubitril; oral

7.0

44.7

116

141

WZA90

NOMESCO Finland

Other doctors statement

1.4

44.6

2938

19115

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

5.9

44.5

132

192

WX890

NOMESCO Finland

Intesive care monitoring

7.5

44.3

110

125

C10AX13

ATC

evolocumab; parenteral

21.4

44.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.1

44.2

254

694

N07BA03

ATC

varenicline; oral

1.8

44.1

832

4038

XF640

NOMESCO Finland

2.9

43.9

285

845

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.5

43.9

376

1313

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

43.8

1851

11081

I24.9

ICD-10 Finland

Acute ischaemic heart disease, unspecified

24.1

43.7

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

43.6

2697

17349

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

7.9

43.6

105

114

P03

ICPC

Feeling depressed

1.7

43.5

1075

5658

I21.20

ICD-10 Finland

Acute transmural myocardial infarction with other localization no detected stenosis of coronary artery

389.7

43.3

B05DA

ATC

Isotonic solutions

5.3

43.3

139

223

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

43.2

902

4516

N03AX18

ATC

lacosamide; systemic

5.5

43.0

135

211

C10BA02

ATC

simvastatin and ezetimibe; oral, topical

4.5

42.9

162

310

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.2

42.9

174

357

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

42.9

1079

5706

K28

ICPC

Limited function/disability (K)

3.9

42.9

185

402

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

42.8

506

2061

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.9

42.8

126

182

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

31.4

42.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

42.5

1204

6568

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

11.2

42.4

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

42.3

4989

35356

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.9

42.1

124

179

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

+∞

42.0

I21.02

ICD-10 Finland

Acute transmural myocardial infarction of anterior wall

+∞

42.0

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.5

41.9

208

509

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.0

41.8

142

243

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

7.0

41.7

108

131

E86

ICD-10 Finland

Volume depletion

3.6

41.6

199

473

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

41.5

618

2764

N06AB10

ATC

escitalopram; oral

1.4

41.4

2690

17431

I49.5

ICD-10 Finland

Sick sinus syndrome

3.3

41.4

224

586

A10BJ06

ATC

semaglutide; parenteral

2.1

41.4

493

2015

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

5.5

41.3

128

197

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

3.3

41.3

222

578

4100X

ICD-9 Finland

Acute myocardial infarction, Of anterolateral wall[INFARCTUS MYOCARDII ACUTUS DEFINITUS,MÄÄRITTELEMÄT]

+∞

41.0

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.7

40.9

146

264

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.8

40.8

823

4077

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.0

40.8

119

170

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

5.6

40.6

125

191

N03AX09

ATC

lamotrigine; oral

1.9

40.6

640

2921

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

40.6

542

2322

I21.12

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

364.1

40.4

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

40.4

826

4109

FN2DB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA) of coronary restenosis

44.2

40.3

TK810

NOMESCO Finland

Hemofiltration

5.7

40.3

122

183

WX722

NOMESCO Finland

PEEP

2.0

40.2

552

2389

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

7.0

40.2

104

126

I61.3

ICD-10 Finland

Intracerebral haemorrhage in brain stem

+∞

40.1

Multi-vessel balloon catheter extension

+∞

40.1

K02.1

ICD-10 Finland

Caries of dentine

1.3

40.0

8041

60730

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

39.9

520

2206

J01MA14

ATC

moxifloxacin; systemic

1.6

39.8

1064

5717

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.2

39.6

225

610

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.6

39.6

299

974

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4.1

39.6

161

332

J01AA02

ATC

doxycycline; systemic

1.3

39.5

11517

90925

K87

ICPC

Hypertension complicated

3.6

39.5

189

449

SPAT1281

SPAT

Other administrative function

1.7

39.4

846

4273

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

39.3

211

549

K80

ICPC

Cardiac arrhythmia NOS

1.8

38.9

773

3812

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

38.9

247

723

R41.0

ICD-10 Finland

Disorientation, unspecified

3.1

38.8

230

643

R13

ICD-10 Finland

Dysphagia

1.8

38.8

687

3265

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.0

38.7

162

343

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

38.7

694

3312

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

38.7

524

2259

CKC12

NOMESCO Finland

Photocoagulation of retina

2.0

38.5

543

2377

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

7.9

38.5

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

38.3

1091

13433

P01AB01

ATC

metronidazole; oral, rectal

1.3

38.3

5530

40064

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

4.0

38.2

160

339

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

38.2

305

1027

I95.1

ICD-10 Finland

Orthostatic hypotension

3.4

38.1

199

508

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.3

38.0

371

1386

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.3

37.9

206

541

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

37.9

370

1380

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

37.9

496

2107

D68.8

ICD-10 Finland

Other specified coagulation defects

3.7

37.9

174

400

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

7.0

37.9

119

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

37.9

546

2411

N29

ICPC

Neurological sympt/complt other

3.0

37.5

232

668

RD210

NOMESCO Finland

2.8

37.3

255

783

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

6.8

37.3

125

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

37.3

235

684

111

Conventional CABG

+∞

37.1

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

18.2

37.1

SPAT1359

SPAT

Use of symptom diary

2.5

37.0

312

1081

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.4

37.0

321

1129

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

5.0

36.9

125

214

Z94.1

ICD-10 Finland

Heart transplant status

10.3

36.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.1

36.9

442

1813

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.4

36.8

336

1214

A10BB01

ATC

glibenclamide; oral

3.8

36.7

162

360

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

21.7

36.6

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

36.6

246

748

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

36.4

1340

7767

K77

ICPC

Heart failure

5.6

36.3

112

172

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

2.8

36.3

245

746

N06AX16

ATC

venlafaxine; oral

1.4

36.2

1961

12280

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

36.2

697

3403

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

36.2

1278

7340

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.9

36.2

157

344

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

+∞

36.2

I21.1

ICD-10 Finland

Acute transmural myocardial infarction of inferior wall

116.2

36.1

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.6

36.0

277

912

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

11.2

36.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.7

35.9

164

376

J01EA01

ATC

trimethoprim; systemic

1.3

35.8

2831

18871

SPAT1312

SPAT

General health counselling

1.3

35.8

3566

24578

M79.1

ICD-10 Finland

Myalgia

1.5

35.7

1560

9375

B01AB04

ATC

dalteparin; parenteral

1.9

35.3

511

2259

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

3.7

35.2

160

365

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.7

35.1

246

767

H26.4

ICD-10 Finland

After-cataract

1.9

35.1

573

2650

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

5.4

35.0

110

173

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

34.8

10292

80560

R52.9

ICD-10 Finland

Pain, unspecified

1.6

34.8

976

5301

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.1

34.8

206

576

B05DB

ATC

Hypertonic solutions

5.3

34.8

111

178

E87.6

ICD-10 Finland

Hypokalaemia

2.3

34.7

346

1305

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

34.6

2561

16886

EBA30

NOMESCO Finland

Excision of root of tooth

1.8

34.6

621

2964

A10BK01

ATC

dapagliflozin; oral

1.9

34.6

567

2625

WX704

NOMESCO Finland

Intubation

1.6

34.5

864

4556

WX720

NOMESCO Finland

Own respiration

2.0

34.5

457

1952

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.6

34.4

125

231

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

4.9

34.4

119

209

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

10.7

34.2

H03AA01

ATC

levothyroxine sodium; systemic

1.3

34.2

2998

20272

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

34.1

1093

6134

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

34.0

691

3429

GBB00

NOMESCO Finland

Tracheostomy

4.0

33.9

142

302

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

9.1

33.8

Z50.1

ICD-10 Finland

Other physical therapy

1.8

33.8

646

3145

W19

ICD-10 Finland

Unspecified fall

1.6

33.6

968

5293

H3600, E113

ICD-10 Finland

4.5

33.6

125

237

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

11.2

33.6

196

Kela drug reimbursment

Paricalcitol and cinacalcet

6.4

33.5

122

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

33.5

1200

6912

R4190

NOMESCO Finland

Nutritional therapy

2.0

33.4

440

1875

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

33.4

1040

5798

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

5.3

33.4

106

169

287

Kela drug reimbursment

Ticagrelor 60 mg

+∞

33.2

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

4.6

33.2

120

221

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

33.1

167

416

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

33.0

659

3253

R2110

NOMESCO Finland

Giving the first information

1.6

33.0

831

4387

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

33.0

163

399

P01

ICPC

Feeling anxious/nervous/tense

1.5

32.9

1055

5923

GD1LA

NOMESCO Finland

3.9

32.8

141

307

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

4.7

32.8

116

209

C10AB05

ATC

fenofibrate; oral

2.7

32.7

242

779

ZZA00

NOMESCO Finland

Split skin graft

2.4

32.6

284

1000

WW502

NOMESCO Finland

Autotransfusion

7.3

32.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

32.6

3063

20899

I20.19

ICD-10 Finland

Angina angiospastic

19.7

32.5

G91.0

ICD-10 Finland

Communicating hydrocephalus

6.8

32.4

106

C09DA01

ATC

losartan and diuretics; oral

1.5

32.3

1141

6547

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

32.3

862

4624

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

32.3

1546

9452

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.4

32.3

119

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

32.2

693

3500

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

32.2

2156

13977

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.6

32.2

116

213

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

9.5

32.2

P76

ICPC

Depressive disorder

1.7

32.2

761

3948

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.0

32.2

136

292

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.3

32.1

126

252

B03XA01

ATC

erythropoietin; parenteral

4.9

32.1

109

188

Q21.10

ICD-10 Finland

Persistent ostium secundum

6.0

32.1

133

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

8.3

32.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

31.9

2208

14389

C07AB03

ATC

atenolol; systemic

2.0

31.9

439

1903

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

11.5

31.9

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

5.9

31.9

134

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

31.9

451

1977

M03BX01

ATC

baclofen; systemic

2.6

31.8

240

782

R33

ICD-10 Finland

Retention of urine

2.0

31.8

406

1711

UKC02

NOMESCO Finland

Cystoscopy

1.5

31.7

1204

7018

N19

ICD-10 Finland

Unspecified kidney failure

2.8

31.5

215

659

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.0

31.5

191

542

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

31.5

6831

51435

N02AC04

ATC

dextropropoxyphene; oral

2.2

31.4

335

1305

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

31.3

719

3699

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

31.2

649

3247

K07

ICPC

Swollen ankles/oedema

2.2

31.2

329

1276

Q21.19

ICD-10 Finland

Atrial septal defect NOS

7.5

31.2

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.9

31.0

129

WX290

NOMESCO Finland

Other blockade of nerve

1.2

30.9

6204

46295

L08

ICPC

Shoulder symptom/complaint

1.3

30.9

2244

14728

I44.2

ICD-10 Finland

Atrioventricular block, complete

3.5

30.8

154

381

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.7

30.8

140

G40.10

ICD-10 Finland

Simple partial seizures

4.5

30.8

113

212

I21.48

ICD-10 Finland

Acute subendocardial infarction other occlusion in coronary artery

278.4

30.8

F80.1

ICD-10 Finland

Expressive language disorder

5.7

30.8

137

SPAT1098

SPAT

Exercise ECG

2.5

30.7

244

820

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.6

30.7

457

6475

JN4BD

NOMESCO Finland

Extensive body CT

1.5

30.7

1086

6234

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

30.6

1185

6936

PD3AT

NOMESCO Finland

Pelvic artery PTA

8.6

30.6

B01AE07

ATC

dabigatran etexilate; oral

2.2

30.5

320

1238

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

9.1

30.5

FXG00

NOMESCO Finland

Insertion and use of IABP

23.9

30.4

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

76.5

30.4

43399

ICD-8 Finland

Cerebral thrombosis, Without mention of hypertension

+∞

30.3

K86

ICPC

Hypertension uncomplicated

1.5

30.1

1058

6061

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

7.3

30.1

PEN23

NOMESCO Finland

Plastic repair of femoral artery

8.0

30.0

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.8

30.0

104

184

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

3.9

30.0

130

286

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

29.9

754

3985

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

10.6

29.8

A10BJ02

ATC

liraglutide; parenteral

2.2

29.8

317

1235

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

29.8

1120

6514

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

29.7

328

1299

I61

ICD-10 Finland

Intracerebral haemorrhage

34.0

29.6

J20

ICD-10 Finland

Acute bronchitis

1.5

29.5

1083

6266

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

29.5

739

3895

R05

ICPC

Cough

1.3

29.4

2555

17206

WW500

NOMESCO Finland

Blood transfusion

2.0

29.4

377

1591

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

29.4

1292

14800

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

29.3

129

288

SPAT1101

SPAT

Orthostatic test

2.3

29.2

292

1103

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

7.0

29.2

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.3

29.2

287

1077

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.2

29.2

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

3.4

29.1

149

376

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

29.1

194

589

C10AA02

ATC

lovastatin; oral

2.5

29.0

236

803

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.2

28.9

114

230

1CX08

NOMESCO Finland

7.8

28.9

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

5.9

28.9

121

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

28.8

519

2481

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.6

28.8

138

331

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

28.7

7325

55867

V03AE03

ATC

lanthanum carbonate; oral

6.3

28.7

106

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

28.7

2666

18120

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.4

28.7

261

943

RF420

NOMESCO Finland

2.8

28.6

196

605

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

5.7

28.6

126

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

28.5

301

1169

J46

ICD-10 Finland

Status asthmaticus

2.1

28.5

322

1287

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

28.5

7013

53275

I20.8

ICD-10 Finland

Other forms of angina pectoris

13.0

28.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.4

28.4

242

846

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

28.4

522

2512

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

8.1

28.3

SPAT1167

SPAT

Insertion of urinary catheter

3.0

28.3

170

482

N083, E102

ICD-10 Finland

21.5

28.2

H02AB07

ATC

prednisone; oral

1.4

28.2

1666

10562

RS230

NOMESCO Finland

4.9

28.2

167

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

28.2

1258

7580

B01AB10

ATC

tinzaparin; parenteral

1.6

28.1

756

4063

H02AB04

ATC

methylprednisolone; systemic

1.4

28.1

1797

11546

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

28.0

927

5242

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

27.9

159

434

S10

ICPC

Boil/carbuncle

1.7

27.9

587

2944

XPX08

NOMESCO Finland

Intraoperative flow measurement

6.0

27.8

114

U04

ICPC

Incontinence urine

2.0

27.8

356

1504

G41.9

ICD-10 Finland

Status epilepticus, unspecified

5.7

27.8

124

PEC23

NOMESCO Finland

Suture of common femoral artery

18.7

27.7

SPAT1211

SPAT

Application of soft bandage

1.5

27.7

874

4886

I48.1

ICD-10 Finland

Persistent atrial fibrillation

3.1

27.6

157

429

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

27.6

384

1676

RS313

NOMESCO Finland

14.6

27.5

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

4.8

27.5

168

SPAT1131

SPAT

Colonoscopy

2.0

27.5

347

1457

L12

ICPC

Hand/finger symptom/complaint

1.4

27.5

1600

10120

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

4.0

27.3

113

239

TFN99

NOMESCO Finland

Catheterisation of heart with other coronary procedure

38.2

27.3

Z50.5

ICD-10 Finland

Speech therapy

3.0

27.3

168

485

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

27.2

611

3124

AAK80

NOMESCO Finland

Partial excision of skull cap

24.3

27.2

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

27.2

710

3787

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.3

27.1

252

922

A29

ICPC

General symptom/complaint other

1.5

27.1

1047

6124

SPAT1058

SPAT

PEF monitoring instruction

1.5

27.0

886

4995

3AC01

NOMESCO Finland

3.4

26.9

135

336

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

7.0

26.9

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

5.7

26.9

119

RS121

NOMESCO Finland

4.6

26.9

176

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

26.8

216

732

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.1

26.8

147

160

Kela drug reimbursment

exenatide

2.2

26.8

273

1043

C07AB08

ATC

celiprolol; oral

2.8

26.7

184

571

S06.3

ICD-10 Finland

Focal brain injury

3.3

26.7

140

361

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

26.7

452

2119

R31

ICD-10 Finland

Unspecified haematuria

1.6

26.6

671

3544

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

26.6

3361

23721

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

26.5

284

1111

R96

ICPC

Asthma

1.5

26.5

953

5490

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

4.1

26.4

106

218

U02

ICPC

Urinary frequency/urgency

1.4

26.4

1333

8215

2503B

ICD-9 Finland

Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]

13.8

26.4

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

13.8

26.4

RF410

NOMESCO Finland

2.9

26.4

168

496

PA7CC

NOMESCO Finland

Very extensive angiography of arteries of neck and brain

15.3

26.3

NGQ20

NOMESCO Finland

Amputation of lower leg

7.8

26.3

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

26.2

348

1492

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.5

26.1

NFQ20

NOMESCO Finland

Amputation of femur

13.3

26.0

I20.08

ICD-10 Finland

Unstable angina

239.0

25.9

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

11.5

25.9

C08CA07

ATC

nisoldipine; oral

7.6

25.9

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

25.9

769

4235

A10AA03

ATC

4.0

25.8

109

235

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

25.8

1322

8169

FN1LE

NOMESCO Finland

Mesurement of coronary artery reserve with iv vasodilatator

123.2

25.8

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

26.2

25.8

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

25.7

1753

11370

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

25.6

513

2536

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

25.5

839

4734

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

6.0

25.4

104

J96.1

ICD-10 Finland

Chronic respiratory failure

3.2

25.4

142

384

A08

ICPC

Swelling

1.9

25.4

365

1615

C08CA10

ATC

nilvadipine; oral

2.7

25.3

184

590

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

7.9

25.3

N06AB03

ATC

fluoxetine; oral

1.4

25.3

1613

10346

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

25.3

257

981

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

25.2

2582

17739

Z08

ICPC

Social welfare problem

2.7

25.2

176

551

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

7.4

25.2

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.5

25.2

124

305

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.8

25.1

1923

20423

K92.0

ICD-10 Finland

Haematemesis

2.4

25.1

212

740

L04AD01

ATC

ciclosporin; systemic

2.2

25.1

267

1044

C08DA01

ATC

verapamil; systemic

1.9

25.1

382

1724

P29

ICPC

Psychological sympt/compl other

1.6

25.0

630

3327

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

6.8

25.0

RJ410

NOMESCO Finland

5.5

25.0

120

I95.9

ICD-10 Finland

Hypotension, unspecified

3.5

24.9

122

299

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

24.9

604

3156

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

4.6

24.9

164

L14

ICPC

Leg/thigh symptom/complaint

1.6

24.8

696

3777

S01.0

ICD-10 Finland

Open wound of scalp

1.6

24.8

710

3874

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

24.8

771

4293

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

6.6

24.8

K05.30

ICD-10 Finland

Periodontitis complex

1.4

24.8

1483

9411

J01CA04

ATC

amoxicillin; systemic

1.2

24.7

11380

91199

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

24.7

285

1152

C09AA01

ATC

captopril; oral

3.8

24.7

108

241

WW200

NOMESCO Finland

Immunization

2.0

24.6

340

1480

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

7.5

24.6

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

24.6

441

2105

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

24.5

857

4903

R95

ICPC

Chron obstructive pulmonary disease

2.4

24.5

208

728

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

24.5

761

4238

RJ411

NOMESCO Finland

4.2

24.5

194

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

24.4

575

2981

I61.2

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, unspecified

+∞

24.4

WX870

NOMESCO Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3027945) Reticulocytes/100 erythrocytes in Blood

6167

23687

1.79

317.87

2.5

2.6

1.9

1.8

15.55

5490

20939

(3044640) Blood type and Crossmatch panel - Blood

14357

68352

1.53

316.62

2.9

2.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3564

11435

2.09

311.33

1.6

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2858

8402

2.27

309.29

6.5

4.6

1.8

1.7

2.69

2683

7910

(3031040) Bacteria [#/volume] in Urine by Automated count

26240

141904

1.50

309.05

5.5

4.3

e6/l

1568.3

1385.7

0.20

402

1970

(3019060) Gas panel - Arterial blood

4817

13106

2.53

307.65

6.2

4.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12193

50660

1.77

307.65

2.6

2.2

mg/l

3.2

2.9

16.82

10644

42954

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9574

34547

2.01

307.65

3.8

3.5

mmol/l

0.8

0.19

8994

32149

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10765

45555

1.69

307.65

2.3

1.7

mg/l

1.3

0.08

8375

35186

(3013826) Glucose [Moles/volume] in Serum or Plasma

29105

126687

2.56

307.65

6.8

4.4

mmol/l

7.0

6.7

84.08

28044

118467

(3024354) Oxygen [Partial pressure] in Venous blood

4771

15439

2.11

307.65

4.0

3.0

kpa

4.7

4.6

3.44

4622

14966

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4441

12963

2.34

307.65

11.3

8.8

1.4

2.05

4415

12875

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3815

11241

2.30

307.65

12.6

9.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2637

6967

2.52

307.65

2.7

2.2

ug/l

544.3

523.4

0.09

2532

6523

(3014111) Lactate [Moles/volume] in Serum or Plasma

5565

18391

2.09

307.65

9.2

6.8

mmol/l

1.4

1.3

2.15

5354

17781

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

7552

15306

3.64

307.65

2.8

2.0

ug/l

10.5

6.0

28.23

6797

13088

(3027801) Oxygen [Partial pressure] in Arterial blood

8018

23233

2.50

307.65

9.2

7.0

kpa

12.1

12.5

9.85

7660

22223

(3012516) Albumin [Mass/volume] in Urine

14990

67663

1.66

307.65

3.5

3.2

mg/l

401.4

429.8

0.31

10155

41548

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

23457

115963

1.68

307.65

6.6

6.5

umol/l

11.8

11.5

1.55

22440

109891

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7609

28141

1.90

307.65

3.4

2.4

20.4

23.4

64.52

6490

23946

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6685

19198

2.47

307.65

10.2

7.7

g/l

120.4

122.2

7.89

6468

18514

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

19495

62168

2.89

307.65

2.6

2.0

u/l

209.2

212.2

0.16

18601

57820

(3014576) Chloride [Moles/volume] in Serum or Plasma

7845

26583

2.10

307.65

8.9

6.9

mmol/l

104.5

104.3

3.69

7672

26046

(3022948) Iron [Moles/volume] in Serum or Plasma

8535

32540

1.86

307.65

3.2

2.4

umol/l

11.7

14.0

3.58

7967

30047

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

20577

100819

1.61

307.65

4.6

3.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2198

5246

2.78

307.65

2.9

2.5

193.1

194.6

0.28

2124

4925

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17605

60393

2.50

307.65

3.7

2.7

ng/l

1862.6

1046.6

60.35

15736

50869

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7978

30128

1.86

307.65

3.2

2.4

g/l

2.3

1.28

7454

27790

(3004119) Hemoglobin [Mass/volume] in Venous blood

3903

12394

2.13

307.65

4.4

3.1

g/l

125.5

130.3

28.78

3806

12134

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3553

11122

2.15

307.65

11.8

9.0

mmol/l

24.3

24.4

1.67

3314

10426

(3043409) Potassium [Moles/volume] in Arterial blood

2309

5852

2.62

307.65

5.7

4.1

mmol/l

3.9

4.78

2187

5517

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7735

27417

1.99

307.65

7.7

5.6

mmol/l

1.1

1.0

21.67

7271

25505

(3033658) Prothrombin time (PT) actual/Normal

13466

55176

1.83

307.65

4.9

3.9

86.0

91.1

92.58

13173

53791

(3009508) Creatinine [Moles/volume] in Urine

15256

70377

1.62

307.65

3.4

3.2

mmol/l

7.2

7.7

26.88

12816

58911

(3000991) Gas panel - Venous blood

5356

17420

2.12

307.65

11.0

8.0

—

(3002032) Base excess in Venous blood by calculation

5784

18901

2.12

307.65

5.0

3.7

mmol/l

1.9

0.36

4760

15566

(3023368) Bacteria identified in Blood by Culture

14689

57928

1.97

307.65

5.0

4.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6535

22659

2.01

307.65

1.9

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

19539

96781

1.55

307.65

5.8

4.8

g/l

34.5

35.5

109.94

18265

89571

(3026008) Bacteria identified in Urine by Culture

13957

62907

1.64

307.65

3.6

3.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5804

18919

2.12

307.65

4.9

3.7

kpa

5.8

1.09

5646

18413

(3020891) Body temperature

2807

8017

2.34

307.65

6.3

4.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8022

23248

2.50

307.65

9.2

7.0

kpa

5.1

5.47

7671

22247

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12884

39256

2.60

307.65

5.7

3.0

ng/l

1125.2

218.9

24.88

11307

30077

(3014007) Fractional oxyhemoglobin in Arterial blood

4467

13036

2.34

307.65

11.5

8.9

93.9

94.0

0.24

4452

12991

(3003396) Base excess in Arterial blood by calculation

7972

23256

2.48

307.65

9.2

7.0

mmol/l

1.1

0.38

6351

18581

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5964

16747

2.50

307.65

3.5

2.5

ng/l

254.3

158.2

35.24

5498

15216

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4465

12903

2.37

307.65

11.5

8.9

0.7

0.94

4438

12829

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

21415

80582

2.44

307.65

5.4

3.0

ng/l

129.6

33.8

4.58

17048

54589

(3012544) pH of Venous blood

6089

19554

2.17

307.65

5.0

3.6

7.4

0.84

110

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

23003

110882

1.74

307.65

9.5

6.4

mmol/l

1.2

149.23

19794

92969

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4547

12332

2.53

307.65

9.2

6.6

mmol/l

24.6

24.7

1.47

4288

11460

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

9094

33258

1.96

307.65

2.0

1.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

2661

6784

2.62

307.65

5.2

3.9

mmol/l

1.4

0.78

2616

6674

(3018677) aPTT in Platelet poor plasma by Coagulation assay

12773

27861

3.79

307.65

2.5

2.0

30.2

29.6

15.61

12465

27015

(3016502) Oxygen saturation in Arterial blood

7297

20677

2.53

307.65

9.6

7.4

95.6

95.8

1.62

7033

19971

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

21083

100756

1.69

307.65

8.7

5.7

mmol/l

1.2

160.63

19540

90668

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2957

6235

3.20

307.65

3.8

2.8

u/ml

0.4

0.3

3.96

1946

3271

(3020779) Urea [Moles/volume] in Serum or Plasma

6016

17951

2.34

307.65

10.0

7.0

mmol/l

10.5

9.6

12.70

5738

17104

(3020682) Albumin/Creatinine [Ratio] in Urine

15706

71300

1.66

307.65

4.3

3.9

mg/mmol

13.6

7.4

27.49

10371

44135

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6529

22655

2.01

307.65

1.9

1.7

—

(3036489) Thrombin time

3345

6468

3.52

307.65

2.3

2.1

21.6

0.02

2959

5599

(3022217) INR in Platelet poor plasma by Coagulation assay

8181

27541

2.13

307.65

28.7

22.6

inr

1.4

1.3

8.09

1066

3969

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2498

5791

2.88

307.65

2.7

2.2

93.2

90.9

4.73

2356

5353

(3032080) INR in Blood by Coagulation assay

23726

86594

2.75

307.65

11.7

8.1

inr

1.3

1.2

4.93

6719

24333

(3007930) Methemoglobin/Hemoglobin.total in Blood

2794

8258

2.25

298.27

6.6

4.7

0.9

0.06

2626

7768

(3044889) 12 lead EKG panel

28773

159156

1.51

297.45

5.3

3.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3824

12815

2.01

296.70

9.7

6.8

mmol/l

24.7

24.9

3.40

3790

12699

(3018418) pH of Serum or Plasma

13791

66019

1.51

289.67

5.1

4.1

7.4

0.56

2919

12334

(3002582) Erythrocytes [#/volume] in Urine

13849

66409

1.51

288.17

3.8

3.2

e6/l

78.4

90.4

0.43

10977

50465

(3051593) INR in Capillary blood by Coagulation assay

582

610

6.19

279.18

6.3

15.2

—

(3030467) Casts [#/volume] in Urine by Automated count

12849

60975

1.51

278.72

3.7

3.1

e6/l

0.5

0.4

3.96

10066

45316

(3019309) Folate [Moles/volume] in Red Blood Cells

9100

40158

1.58

272.90

1.8

1.7

nmol/l

1185.7

1161.6

1.54

7099

29914

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1282

2652

3.17

271.95

1.1

117.6

118.4

0.33

1210

2355

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30770

173925

1.51

269.80

8.9

7.7

u/l

81.5

78.6

17.13

29276

163390

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1285

2692

3.13

267.07

1.3

1.2

u/ml

4.5

3.6

1.52

579

1213

(4306422)

1302

2758

3.09

265.77

1.2

—

(3000850) Epithelial cells [#/volume] in Urine

10019

45572

1.54

261.18

3.0

2.6

e6/l

5.2

5.1

0.53

8900

39640

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

14302

70113

1.47

259.68

3.0

2.6

u/l

57.1

59.1

3.02

13344

64292

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11189

52230

1.51

258.14

2.8

2.3

—

(3006315) Basophils [#/volume] in Blood

20748

109218

1.43

257.55

6.4

6.0

e9/l

0.0

1.44

18037

93732

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2975

9561

2.07

256.78

3.5

2.7

1.3

2.03

2954

9517

(3027273) Bicarbonate [Moles/volume] in Venous blood

3043

9877

2.05

255.81

4.3

3.2

mmol/l

25.2

25.3

0.90

2968

9590

(36304419) Bacteria [Presence] in Urine

12374

59072

1.49

255.64

3.6

3.0

—

(3001604) Monocytes [#/volume] in Blood

20644

108669

1.43

255.39

6.4

6.0

e9/l

0.6

70.14

17920

93267

(3026782) Osmolality of Urine

9389

42341

1.55

253.07

3.2

2.7

mosm/kgh2o

534.3

550.9

10.19

8151

35864

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2026

5594

2.39

251.05

3.2

2.5

g/l

3.6

3.7

0.74

1949

5340

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2980

9688

2.05

249.21

5.6

4.0

mmol/l

24.0

24.3

2.87

2663

8696

(3018095) Leukocytes [#/volume] in Urine

15412

77122

1.45

248.36

4.4

3.6

e6/l

108.0

96.3

0.63

11606

54464

(3019198) Lymphocytes [#/volume] in Blood

21040

111637

1.42

244.65

6.4

6.0

e9/l

1.9

4.57

18549

97511

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2892

9374

2.05

243.58

3.5

2.7

0.7

0.28

2792

8958

(3013115) Eosinophils [#/volume] in Blood

21209

112781

1.42

242.82

6.6

6.2

e9/l

0.2

6.60

18713

98168

(3023520) Reticulocytes [#/volume] in Blood

4691

17881

1.77

242.81

2.6

2.7

e9/l

72.4

69.1

7.29

3589

13507

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6099

25067

1.66

240.28

4.4

4.5

u/l

251.1

242.6

2.81

5762

23703

(3013650) Neutrophils [#/volume] in Blood by Automated count

23359

126555

1.42

239.02

9.1

9.6

e9/l

4.5

4.0

112.91

20488

110029

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2824

9140

2.05

238.63

4.8

3.7

50.4

47.8

5.82

2796

9039

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1265

2816

2.94

237.37

1.3

1.2

u/ml

4.8

3.6

0.81

413

995

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17696

91469

1.42

234.49

2.2

1.9

pmol/l

93.9

96.3

8.29

9498

46793

(3047181) Lactate [Moles/volume] in Blood

2141

6307

2.24

228.72

8.0

5.4

mmol/l

1.3

1.01

1910

5578

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1239

2786

2.91

228.41

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

10686

50460

1.48

227.39

1.6

1.5

nmol/l

19.4

20.8

14.78

9321

42660

(3022096) Basophils/100 leukocytes in Blood

18835

99127

1.40

219.87

6.7

6.2

0.7

13.98

17765

92159

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4074

15355

1.78

217.56

1.8

1.6

—

(3006504) Eosinophils/100 leukocytes in Blood

19280

102109

1.39

215.04

6.7

6.2

2.8

2.9

3.69

18164

94893

(3007853) Bacteria identified in Skin by Aerobe culture

5968

25058

1.62

213.71

2.1

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2785

9325

1.98

213.69

1.7

g/l

1.6

3.26

2402

7921

(3019069) Monocytes/100 leukocytes in Blood

19353

102704

1.39

212.13

7.0

6.5

8.9

8.7

16.74

18288

95884

(3039000) Anion gap in Blood

1631

4442

2.41

207.50

9.0

6.3

mmol/l

11.2

0.38

1475

4025

(3018572) Chloride [Moles/volume] in Blood

1631

4443

2.41

207.40

9.0

6.3

mmol/l

105.3

104.9

1.92

1476

4026

(3037467) Urinalysis macro (dipstick) panel - Urine

26802

150620

1.39

204.44

5.2

4.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

16349

84737

1.39

203.31

3.5

2.7

ug/l

154.0

150.3

0.40

15105

77750

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2542

8442

1.99

199.11

2.2

2.0

ug/l

2.1

2.3

0.33

2231

7468

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3376

12329

1.82

199.08

1.8

1.6

—

(3042936) Bacteria identified in Isolate by Culture

7035

31258

1.53

195.68

2.4

2.0

—

(3018010) Neutrophils/100 leukocytes in Blood

19364

103630

1.37

195.15

6.6

6.1

59.1

57.0

97.88

18257

96582

(3002030) Lymphocytes/100 leukocytes in Blood

19610

105231

1.37

193.76

6.8

6.3

25.7

28.0

140.74

18426

97663

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

945

2018

3.05

189.93

1.2

1.1

96.2

97.1

0.47

917

1859

(3004451) EKG impression Narrative

547

791

4.48

188.81

1.4

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3577

13515

1.76

187.97

4.5

3.5

kpa

5.1

5.2

1.16

3321

12451

(3009343) pH of Capillary blood

3537

13321

1.77

187.91

4.5

3.5

7.4

1.43

498

1739

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13984

71335

1.39

186.46

3.5

3.3

u/l

37.8

34.2

2.70

13255

67453

(42870588) Differential panel, method unspecified - Blood

14653

75656

1.37

179.64

6.3

6.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1545

4397

2.30

177.99

2.6

3.0

umol/l

31.6

35.6

8.18

1323

3736

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3403

12876

1.76

177.47

4.4

3.4

mmol/l

1.8

0.09

2523

9687

(3024928) Oxygen saturation in Venous blood

1479

4175

2.32

173.50

4.4

3.1

—

(4268621)

860

1834

3.05

173.18

2.5

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1849

5755

2.11

171.57

1.3

—

(3021589) Normoblasts [#/volume] in Blood

18020

97173

1.33

160.42

12.1

9.6

e9/l

0.0

0.23

15025

79535

(3013707) Erythrocyte sedimentation rate by Westergren method

28520

164552

1.35

159.14

4.7

4.1

mm/h

14.5

12.3

92.69

26806

151436

(21494755) Public health laboratory ask at order entry panel

1576

19653

0.50

157.20

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

34876

208265

1.45

156.01

7.8

5.7

mmol/mol

42.5

39.7

307.65

32871

191307

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

7969

38235

1.42

144.52

3.1

2.7

e6/l

1.2

0.16

4740

21671

(3013512) EKG study

12837

66723

1.34

141.36

5.4

3.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1283

3726

2.25

140.70

3.1

nmol/l

0.8

0.80

971

2892

(3020630) Protein [Mass/volume] in Serum or Plasma

4324

18461

1.56

139.50

2.4

2.7

g/l

65.7

66.7

11.11

3942

16767

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

319

372

5.54

138.57

10.2

7.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1603

5182

2.02

134.09

3.7

2.9

mmol/l

24.7

24.9

1.10

1412

4536

(3028626) Oxygen [Partial pressure] in Capillary blood

1451

4520

2.10

133.87

3.8

3.1

kpa

8.1

8.2

1.90

1350

4188

(3026493) Urate [Moles/volume] in Serum or Plasma

11728

60644

1.33

131.48

3.1

2.6

umol/l

3564.2

4797.7

2.82

10118

52553

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

7371

35393

1.41

131.38

3.4

2.9

e6/l

2.5

2.6

0.38

4206

18930

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

36407

220640

1.45

130.09

22.7

13.5

mg/l

24.8

24.5

0.63

31823

173357

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1020

2821

2.35

124.92

7.2

6.1

mg/l

11.6

0.15

938

2590

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3859

16482

1.55

123.36

5.1

3.6

ng/l

113.8

86.2

36.94

3345

14098

(3038071) Oxygen [Partial pressure] in Mixed venous blood

283

330

5.53

122.98

10.0

7.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9270

46681

1.35

122.22

1.8

1.7

pmol/l

33610610.2

33991012.0

0.02

7706

38190

(3035350) Ketones [Presence] in Urine by Test strip

19181

106846

1.28

120.39

4.4

3.6

estimate

0.0

1.54

4038

18967

(3006576) Bicarbonate [Moles/volume] in Blood

377

589

4.13

118.67

8.1

5.2

mmol/l

25.6

25.0

1.72

340

546

(3021901) Oxygen saturation in Capillary blood

1227

3758

2.13

118.06

3.3

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

19374

108477

1.27

114.19

4.5

3.6

estimate

0.0

0.16

3878

18933

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4922

22505

1.46

112.83

4.2

3.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

595

1316

2.93

112.64

1.3

1.4

umol/l

13.2

12.7

0.87

568

1251

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1765

19312

0.57

111.27

2.0

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2427

9482

1.68

110.91

1.4

1.6

u/ml

12.8

16.5

0.42

260

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

230

240

6.18

110.91

7.7

6.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5399

25223

1.43

110.11

2.8

umol/l

8.4

9.3

2.02

4744

22044

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4664

21209

1.46

109.75

2.2

2.3

g/l

0.2

7.80

4300

19729

(3021601) Nitrite [Presence] in Urine by Test strip

19138

107311

1.27

109.63

5.8

4.8

estimate

0.0

0.45

4081

19412

(3010421) pH of Blood

1605

5611

1.87

106.75

5.0

3.7

7.4

1.46

1354

4795

(3022313) Gas panel - Capillary blood

2475

9819

1.66

106.60

4.7

3.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

412

750

3.55

105.84

1.2

1.1

u/ml

6.4

14.9

0.75

(40767503) Oxygen content in Capillary blood by calculation

1362

4554

1.95

103.38

2.9

2.5

16.2

16.5

1.89

727

2358

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4207

18958

1.47

103.25

2.2

2.4

nmol/l

367.6

371.3

0.51

3853

17472

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4080

18274

1.48

103.25

4.5

3.8

mmol/l

1.2

11.99

3731

15780

(3004588) Protein electrophoresis panel - Serum or Plasma

3528

15336

1.52

103.12

2.2

2.5

—

(3029937) Albumin [Presence] in Urine by Test strip

10906

57349

1.30

102.68

5.0

4.0

estimate

0.0

0.22

3813

18710

(40761535) Cells panel - Urine sediment

3987

17907

1.47

99.27

4.0

3.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1935

7347

1.72

97.82

1.6

titre

222.9

262.4

0.30

322

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1446

5045

1.87

96.66

1.5

1.3

mg/l

602.9

555.8

0.66

1380

4807

(3011397) Hemoglobin [Presence] in Urine by Test strip

9740

50808

1.30

96.17

4.2

3.6

—

(3015736) pH of Urine

15063

82948

1.26

96.06

4.1

3.4

5.9

5.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1307

4425

1.92

95.61

1.6

1.4

e6/l

22.1

32.5

1.00

1039

3389

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1307

4429

1.92

95.36

1.7

1.4

e6/l

4657.7

2096.7

0.44

1084

3597

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1480

5258

1.84

93.46

2.5

2.4

ug/min

155.3

96.1

3.62

893

3080

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1031

12541

0.52

92.88

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

471

1018

2.99

92.79

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4401

20471

1.42

90.54

2.8

2.5

u/l

53.8

46.1

0.19

3738

17560

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

475

1052

2.92

89.78

1.2

1.1

ratio

1.1

1.17

159

375

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1290

4443

1.89

89.63

1.4

1.2

mmol/l

4.0

3.8

6.97

1216

4184

(3027315) Oxygen [Partial pressure] in Blood

1397

4939

1.84

89.55

5.0

3.8

kpa

8.5

8.6

0.79

1364

4826

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1261

4315

1.90

89.34

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1261

4317

1.90

89.21

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1708

6431

1.73

88.79

4.0

3.1

—

(1616796) Gas panel - Central venous blood

1351

4741

1.86

88.63

4.5

3.5

—

(3012501) Base excess in Blood by calculation

1386

4904

1.84

88.61

5.0

3.8

mmol/l

2.4

2.6

1.47

979

3411

(3013290) Carbon dioxide [Partial pressure] in Blood

1386

4906

1.84

88.50

5.0

3.8

kpa

5.0

0.22

1353

4794

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2022

8002

1.65

87.49

1.9

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

1038

3380

2.00

84.80

2.1

1.8

mmol/l

1.8

1.7

0.35

1004

3312

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

364

709

3.31

84.74

2.2

2.3

umol/l

58.5

53.0

2.29

284

580

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2158

8778

1.61

83.65

2.0

1.9

—

(40758558) Short blood count panel - Blood

10446

55990

1.26

80.21

7.2

—

(3008037) Lactate [Moles/volume] in Venous blood

1293

4619

1.82

80.12

3.9

2.9

mmol/l

1.6

0.78

1266

4521

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

670

1877

2.31

79.71

1.9

1.4

—

(3034426) Prothrombin time (PT)

322

607

3.42

78.76

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1684

6528

1.68

78.67

1.9

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

372

774

3.10

78.12

1.0

1.1

98.9

99.6

0.13

320

602

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3223

28694

0.70

77.24

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1184

4175

1.84

76.44

1.6

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1330

4914

1.76

73.67

2.5

2.1

g/l

128.8

130.8

1.77

999

3467

(3015377) Calcium [Moles/volume] in Serum or Plasma

13654

76006

1.23

72.73

3.4

3.5

mmol/l

2.3

2.4

13.33

11875

65985

(3017181) Myelocytes/100 leukocytes in Blood

4003

18991

1.39

72.48

4.4

4.1

0.9

1.0

0.59

1186

5545

(3002179) Metamyelocytes/100 leukocytes in Blood

3671

17191

1.41

71.67

4.2

4.0

0.6

0.7

0.39

865

3996

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

294

557

3.40

71.43

1.1

—

(3003181) Sodium [Moles/volume] in Urine

1073

3747

1.86

71.39

1.4

mmol/l

66.0

61.3

2.74

858

2940

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1546

6029

1.67

70.53

1.6

1.4

iu/ml

15.0

15.5

0.05

140

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1350

5077

1.73

70.30

1.6

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3825

18154

1.39

68.88

3.2

2.6

ml/min/173m2

58.9

66.1

22.65

1657

6949

(3022806) Fractional oxyhemoglobin in Capillary blood

831

2693

2.00

68.79

2.0

1.8

89.4

89.7

0.83

811

2659

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1306

4906

1.73

68.27

1.6

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1586

6289

1.64

67.83

1.7

1.6

g/l

1.2

1.57

1509

5988

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1545

6090

1.65

67.63

1.7

1.6

g/l

0.2

2.19

1471

5767

(3021440) Promyelocytes/100 leukocytes in Blood

3794

18051

1.38

67.23

4.4

4.2

0.1

0.67

1096

5139

(3005719) IgG [Mass/volume] in Serum or Plasma

3458

16204

1.40

67.03

2.7

2.8

g/l

10.5

10.6

1.01

3188

14768

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2049

8663

1.54

67.01

5.0

3.7

mmol/l

24.8

24.9

1.70

1881

8004

(3019150) Specific gravity of Urine by Refractometry

8657

46227

1.25

66.31

5.0

4.0

kg/l

1.0

0.00

1355

6922

(3038515) Glucose [Moles/volume] in Venous blood

1189

4407

1.75

65.11

4.1

3.0

mmol/l

7.9

7.5

4.14

1169

4322

(3025159) Blasts/100 leukocytes in Blood

3576

16937

1.39

65.00

4.4

4.2

0.1

0.2

0.41

931

4325

(1761868) Lipid panel - Serum or Plasma

10801

80266

0.82

64.55

3.7

2.9

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1305

4982

1.70

64.37

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11018

60586

1.23

64.04

1.8

1.6

mmol/l

1.4

4.29

9331

50247

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1727

7118

1.58

63.05

2.9

3.6

mg/l

42.5

44.8

0.25

1424

5753

(3034860) Kappa light chains.free [Mass/volume] in Serum

1724

7132

1.57

61.94

2.9

3.6

mg/l

91.0

63.0

0.40

1423

5760

(3045716) Anion gap in Serum or Plasma

364

860

2.73

61.45

2.5

2.4

mmol/l

9.4

9.0

0.84

287

601

(3040151) Glucose [Moles/volume] in Capillary blood

714

2284

2.02

61.27

17.8

5.4

mmol/l

7.7

7.3

1.87

601

1866

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7760

41257

1.25

60.95

3.0

3.2

mmol/l

2.5

3.73

6706

36249

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

268

531

3.25

60.93

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1676

6918

1.58

60.78

2.9

3.6

ratio

2.2

4.0

0.91

144

504

(3044242) Glucose [Moles/volume] in Arterial blood

364

867

2.71

60.54

1.8

2.1

—

(3017569) Oxygen content in Arterial blood

367

881

2.69

60.15

2.0

2.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14539

82523

1.20

60.02

4.8

3.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

374

924

2.61

58.03

37.5

34.2

ug/l

7.3

7.4

0.21

344

824

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

484

1359

2.30

57.41

2.1

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

37404

232343

1.31

57.34

28.1

15.2

mmol/l

139.4

139.7

81.57

36934

226370

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1126

4268

1.71

56.98

1.3

1.2

titre

90.0

143.4

0.81

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24432

145535

1.19

56.71

3.8

3.1

u/l

62.0

51.5

36.80

22912

134703

(3001019) Free T4 and TSH panel - Serum or Plasma

853

9491

0.57

55.85

1.7

—

(3051651) Icteric interference index of Serum or Plasma

434

1175

2.38

55.82

4.4

3.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

341

822

2.68

55.50

11.5

3.5

mg/l

1193.7

2141.3

0.42

267

564

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1014

3762

1.75

55.34

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

597

1858

2.08

55.15

2.2

2.5

0.2

0.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

1332

5326

1.62

55.04

2.9

3.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

804

2794

1.86

54.33

1.5

g/l

30.4

34.3

12.91

717

2553

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

817

2854

1.85

54.33

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

618

1962

2.04

54.17

3.1

2.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1809

7797

1.51

53.96

2.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1866

8100

1.50

53.80

2.3

g/l

10.2

0.11

1543

6741

(3035285) Chloride [Moles/volume] in Venous blood

745

2536

1.90

53.61

2.9

2.2

mmol/l

105.8

105.4

1.36

737

2519

(3041354) Potassium [Moles/volume] in Venous blood

745

2537

1.90

53.55

2.9

2.2

mmol/l

4.1

4.0

2.43

737

2520

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1973

8677

1.48

53.37

2.3

g/l

3.8

3.9

0.27

1419

6145

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5520

28584

1.28

53.28

10.4

6.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

888

3205

1.79

53.19

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1976

8705

1.48

52.99

2.3

g/l

7.6

7.4

7.17

1453

6476

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

389

1027

2.44

52.83

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1971

8697

1.48

52.42

2.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

504

1501

2.17

52.07

1.4

1.2

mmol/l

2.2

0.50

463

1401

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

806

2843

1.84

52.00

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1125

4376

1.67

51.74

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

727

2497

1.88

50.94

2.9

2.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32832

201493

1.21

50.72

5.3

4.6

mu/l

2.1

2.2

0.10

30329

183000

(3023103) Potassium [Moles/volume] in Serum or Plasma

37432

233070

1.29

50.35

28.3

15.3

mmol/l

4.0

99.12

36919

226718

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

391

1067

2.36

49.50

1.1

—

(3042733) HLA Ab [Presence] in Serum

299

719

2.68

48.96

5.2

4.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1844

8183

1.47

47.59

2.4

g/l

3.1

3.0

3.51

1432

6307

(3028026) IgM [Mass/volume] in Serum or Plasma

2670

12668

1.38

47.42

1.8

2.0

g/l

1.2

1.4

4.62

2433

11499

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1131

4523

1.62

46.69

6.6

5.8

iu/ml

1740.4

2005.5

0.08

196

690

(44790048)

658

2256

1.89

46.39

1.6

—

(44806118)

658

2256

1.89

46.39

1.6

—

(44790049)

657

2256

1.88

46.11

1.6

—

(44790047)

657

2256

1.88

46.11

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

713

2514

1.83

46.10

1.5

e6/l

2505.0

3597.4

0.74

533

1813

(3000963) Hemoglobin [Mass/volume] in Blood

37660

247172

0.78

45.76

33.4

20.2

g/l

133.0

136.7

307.65

37297

243371

(3051611) Lipemic interference index of Serum or Plasma

650

2233

1.88

45.56

4.2

3.3

—

(3010813) Leukocytes [#/volume] in Blood

37656

247136

0.78

45.53

33.2

20.1

e9/l

7.2

6.6

308.44

36819

239289

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

975

3781

1.67

45.38

1.6

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

37654

247114

0.78

45.34

33.2

20.1

e12/l

4.4

4.5

296.63

36806

239261

(3020191) Ethanol [Moles/volume] in Serum or Plasma

525

1679

2.02

45.20

1.5

promille

1.4

0.48

394

1303

(3024731) MCV [Entitic volume]

37653

247100

0.78

45.20

33.1

20.0

91.6

91.2

42.39

37286

243274

(3035941) MCH [Entitic mass]

37650

247058

0.78

44.76

33.0

20.0

30.4

0.29

37283

243242

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

302

765

2.54

44.74

2.1

167.1

152.9

1.81

288

708

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

378

1075

2.27

43.68

2.1

2.3

96.2

97.4

0.24

364

1009

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

571

1909

1.93

43.42

1.2

1.3

nmol/l

1.6

1.4

4.03

511

1718

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1534

6710

1.48

42.52

2.4

2.3

g/l

36.6

37.9

10.91

1314

5741

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

15566

90663

1.16

42.29

2.5

2.2

nmol/l

76.4

1091.3

0.50

13887

80965

(3007461) Platelets [#/volume] in Blood

37652

246924

0.78

42.26

33.2

20.1

e9/l

244.3

249.5

39.94

36950

239858

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

899

3481

1.67

42.10

1.3

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

4071

20914

1.28

41.10

1.8

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

34394

212993

1.20

41.00

5.3

3.9

mmol/l

1.4

1.3

35.14

32150

193058

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

182

364

3.22

40.97

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

583

2002

1.88

40.97

1.9

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

580

1991

1.88

40.80

1.1

au/ml

74.8

71.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1348

5810

1.50

40.13

4.0

3.1

mg/l

1.9

1.5

30.09

1240

5315

(3036782) Glucose [Moles/volume] in Pleural fluid

562

1920

1.89

40.12

1.4

mmol/l

7.1

6.0

11.24

521

1769

(3016018) Differential panel - Cerebral spinal fluid

619

2192

1.82

39.54

1.8

1.4

—

(3011985) Renin [Units/volume] in Plasma

775

2934

1.71

39.46

1.4

1.5

mu/l

89.6

58.9

1.94

691

2608

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1467

6456

1.47

39.44

2.4

g/l

0.0

0.16

1333

5906

(3023419) Bacteria identified in Sputum by Culture

737

2757

1.73

39.16

2.2

2.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

234

562

2.68

38.54

2.1

203.5

179.1

2.17

229

524

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

27329

166418

1.15

38.24

4.3

3.9

pmol/l

15.0

14.9

17.46

24976

150364

(3010375) cycloSPORINE [Mass/volume] in Blood

337

968

2.24

38.13

25.5

30.4

ug/l

109.9

119.2

1.64

255

830

(3019977) pH of Arterial blood

375

1127

2.15

38.04

2.4

2.5

7.4

0.55

123

427

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1370

5992

1.48

37.98

2.5

2.4

g/l

0.0

0.19

1241

5459

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1747

15403

0.72

37.90

1.3

—

(40768797) Stomach Pathology biopsy report

5853

31580

1.22

37.85

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

633

2292

1.78

37.63

1.5

e6/l

50895.5

57556.7

0.21

396

1346

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1634

7408

1.43

37.60

2.5

g/l

0.8

1.0

1.24

1406

6316

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

630

2279

1.79

37.57

1.5

1.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1350

5902

1.48

37.51

2.5

2.4

g/l

0.0

0.00

1236

5443

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

555

1933

1.85

37.39

1.3

u/l

330.3

540.8

3.36

527

1840

(3037756) Immunofixation for Serum or Plasma

1132

4775

1.54

37.26

1.5

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

5423

29078

1.23

37.22

1.4

1.3

titre

554.1

537.7

0.25

1201

6007

(3009466) Valproate [Moles/volume] in Serum or Plasma

764

2930

1.69

37.13

4.6

5.2

umol/l

356.6

367.0

1.16

669

2517

(4027681)

352

1047

2.17

36.65

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

722

2738

1.70

36.57

1.3

pmol/l

270.9

289.9

0.53

564

2128

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

183

395

2.98

36.48

4.7

6.8

68.7

70.9

0.46

145

309

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

410

1298

2.04

36.39

1.1

—

(3045788) Cell count panel - Pleural fluid

545

1908

1.84

36.14

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

790

3095

1.65

35.44

1.4

1.3

nmol/l

0.2

0.01

213

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

779

3044

1.65

35.29

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

855

3443

1.61

34.39

3.0

2.8

u/ml

953.7

5598.1

0.94

206

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

265

718

2.38

34.26

3.0

umol/l

30.6

27.9

2.89

195

554

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

346

1052

2.12

34.15

2.2

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

785

3101

1.64

34.11

1.4

1.3

nmol/l

2.0

1.3

0.22

755

2990

(3016038) Potassium [Moles/volume] in Urine

416

1359

1.97

33.92

1.2

mmol/l

34.0

34.5

0.16

359

1153

(3008295) Osmolality of Serum or Plasma

571

2071

1.78

33.80

1.4

mosm/kgh2o

280.5

277.3

2.24

468

1599

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

576

2119

1.75

32.52

1.6

1.8

—

(3037121) Protein [Mass/volume] in Urine

1630

7578

1.40

32.52

3.0

3.3

g/l

0.4

0.3

3.30

729

3336

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1958

9384

1.36

32.40

1.8

2.0

u/l

37.3

39.9

5.77

1617

8308

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4202

22236

1.24

32.36

1.5

1.6

—

(4094501)

1439

6551

1.42

32.36

1.1

—

(3012441) Differential panel - Pleural fluid

591

2194

1.74

32.34

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

428

1443

1.91

31.90

1.2

1.1

mg/l

43.8

45.3

0.19

358

1197

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

505

1807

1.80

31.31

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

965

4093

1.52

31.02

1.7

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

155

335

2.98

30.92

1.3

1.2

86.7

87.4

0.05

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

687

2692

1.65

30.85

1.4

1.3

nmol/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

592

6219

0.61

30.85

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

884

3682

1.55

30.84

1.7

1.4

u/ml

128.4

111.9

1.12

194

825

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

121

224

3.47

30.73

2.7

3.5

umol/l

42.1

40.1

0.40

104

193

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

154

333

2.97

30.70

1.3

1.2

74.7

77.2

0.23

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1135

4994

1.47

30.57

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

289

860

2.16

30.17

2.5

2.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

710

2824

1.62

30.08

1.4

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

955

4071

1.52

30.00

1.7

1.4

u/ml

18.6

19.7

0.10

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

409

1390

1.90

29.81

1.1

mg/l

280.6

301.0

0.88

346

1221

(21494890) Protein electrophoresis panel - 24 hour Urine

611

2346

1.68

29.66

1.8

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

626

2425

1.67

29.40

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

707

2829

1.61

29.25

2.0

2.3

32.1

32.8

3.32

697

2812

(3000330) Specific gravity of Urine by Test strip

2236

11096

1.31

29.11

4.0

3.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1391

6422

1.40

28.90

1.9

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

849

3567

1.54

28.53

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4229

22692

1.22

28.26

1.8

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2506

12676

1.29

28.23

3.1

3.3

pmol/l

4.3

4.5

7.98

2229

11201

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

153

348

2.83

28.00

1.3

107.9

110.4

0.32

147

331

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1032

4538

1.47

27.91

2.3

1.7

nmol/l

0.9

0.8

3.04

843

3810

(40760892) CBC W Ordered Manual Differential panel - Blood

8295

47242

1.16

27.65

5.2

4.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

359

1199

1.93

27.59

1.8

1.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

201

531

2.44

27.56

1.2

1.1

83.3

88.6

1.16

100

251

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

198

520

2.45

27.48

1.2

1.1

81.3

89.3

1.57

249

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

924

3987

1.50

27.43

4.6

3.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

202

537

2.42

27.33

1.2

1.1

101.1

107.1

1.19

186

488

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

307

974

2.03

27.25

1.3

1.2

63.0

61.1

0.13

101

(3022621) pH of Urine by Test strip

2754

14162

1.27

27.12

3.4

2.8

—

(44806071)

117

231

3.26

27.06

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

119

238

3.21

26.98

1.6

1.5

ug/l

139.8

99.6

2.72

105

181

(3035880) pH of Pleural fluid

343

1143

1.93

26.56

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

836

3557

1.52

26.54

1.2

1.3

u/l

30.7

37.4

0.97

732

3082

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

207

566

2.35

26.38

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1695

8205

1.34

26.24

1.2

u/ml

0.8

0.9

0.12

152

735

(3049717) Cytology report of Urine Cyto stain

1823

8922

1.33

26.18

2.7

—

(3014271) Vancomycin [Susceptibility]

324

1069

1.95

25.83

3.1

2.9

—

(40768806) Pleura Pathology biopsy report

572

2241

1.65

25.79

1.5

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

392

1386

1.82

25.37

1.4

—

(40768804) Tissue Pathology biopsy report

13370

92837

0.89

25.21

2.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

281

889

2.03

25.18

2.5

3.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

831

3573

1.50

25.13

1.3

u/ml

308.6

276.9

1.90

556

2294

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1282

5981

1.39

25.08

1.9

2.1

mg/l

11.6

11.0

1.51

1191

5556

(3034770) Mitochondria Ab [Titer] in Serum

1285

6001

1.39

24.99

1.2

titre

826.5

1004.6

0.57

181

(3044009) aPTT.lupus sensitive (LA screen)

151

3.70

24.28

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

1287

6043

1.38

24.23

1.2

titre

108.8

128.1

0.42

113

533

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

14092

83661

1.12

24.14

4.6

4.8

ug/l

2.8

3.1

0.91

12645

75787

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

382

1363

1.81

24.04

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

451

1690

1.72

24.03

1.5

—

(3024316) Viscosity of Plasma

4.46

23.95

1.3

2.2

mpas

1.4

1.9

4.94

(3002385) Erythrocyte distribution width [Ratio]

29410

181954

1.12

23.91

26.8

16.7

14.0

13.7

136.37

28969

178009

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

872

3826

1.47

23.90

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

9944

57826

1.14

23.89

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

305

1015

1.93

23.78

2.3

2.1

ug/min

216.4

75.7

0.97

228

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

135

315

2.76

23.68

4.9

5.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2305

11813

1.27

23.29

3.4

2.6

e6/l

0.3

0.05

2266

11511

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

811

7486

0.69

22.87

2.0

1.7

mg/l

4.3

3.5

0.95

630

5351

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

489

1913

1.65

22.26

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

489

1913

1.65

22.26

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

489

1913

1.65

22.26

1.5

1.7

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

233

722

2.08

22.13

1.4

62.0

61.9

0.01

187

603

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

293

988

1.91

22.02

1.1

u/l

1.1

0.03

136

487

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1051

4852

1.40

21.92

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

445

1706

1.68

21.88

1.2

titre

145.8

185.4

0.57

275

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

444

1703

1.68

21.79

1.2

titre

99.5

193.8

1.11

(3025941) Bacteria identified in Stool by Culture

2276

11759

1.26

21.46

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2328

12080

1.25

21.13

2.5

2.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

207

625

2.13

21.04

1.2

16.8

26.3

1.15

(3024932) HLA-DR beta [Type]

235

748

2.02

20.83

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

520

2102

1.59

20.80

1.1

—

(3024471) HLA-A [Type]

239

766

2.01

20.79

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9776

57245

1.12

20.38

4.2

3.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

588

5642

0.66

20.37

1.5

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

327

1176

1.79

20.16

1.3

1.4

nmol/l

1.2

0.17

254

909

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

253

837

1.95

20.16

1.9

1.8

umol/l

81.9

127.9

2.88

125

426

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

490

2.26

20.13

1.2

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

583

2439

1.54

20.12

1.2

u/l

55.0

64.5

2.81

401

1634

(3025315) Body weight

166

3.29

20.12

5.6

4.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

149

399

2.40

20.01

1.1

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1398

6851

1.32

19.92

1.4

ug/g

257.4

269.3

1.28

825

4014

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

409

1578

1.67

19.70

1.3

u/l

12.0

14.7

1.33

370

1470

(40757494) Bilirubin.total [Moles/volume] in Blood

324

1172

1.78

19.61

2.0

2.2

umol/l

36.3

32.9

0.10

102

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

455

2.29

19.60

1.1

—

(40768446) Kidney Pathology biopsy report

254

853

1.92

19.40

1.9

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

590

5601

0.67

19.38

1.7

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

471

1895

1.60

19.25

1.8

2.0

g/24h

1.4

0.9

0.41

100

(3052592) Norovirus Ag [Presence] in Stool

140

371

2.43

19.25

1.4

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1553

12648

0.78

19.00

1.6

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

398

1545

1.66

18.76

1.4

1.5

u/l

13.8

12.5

3.11

385

1493

(3019174) dRVVT (LA screen)

151

3.32

18.74

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

603

2.08

18.72

2.7

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

195

603

2.08

18.72

2.7

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

30471

201037

0.90

18.68

24.7

14.6

38.8

40.1

80.60

19781

142566

(3004775) Volume in Urine collected for unspecified duration

447

1792

1.61

18.56

2.4

2.2

704.0

686.0

0.36

309

1212

(3017704) Immunofixation for Urine

326

1202

1.75

18.53

1.4

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1066

5075

1.36

18.49

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

129

337

2.46

18.30

1.1

mg/g

8.0

0.03

122

319

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

540

5147

0.67

18.13

1.4

1.5

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

120

3.59

18.03

2.4

3.2

mg/l

1.7

2.2

1.67

101

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

168

498

2.17

17.96

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

549

2331

1.52

17.78

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

168

2145

0.50

17.72

1.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

167

498

2.16

17.60

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1233

6043

1.32

17.60

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1022

4872

1.35

17.59

2.5

2.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

107

261

2.63

17.42

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1079

5195

1.34

17.41

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

1233

6055

1.32

17.36

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1222

6003

1.32

17.16

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

191

2.93

17.14

1.3

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

247

858

1.85

17.11

3.4

2.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

6780

39198

1.13

17.01

1.5

g/l

2.7

2.5

4.39

4041

23386

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

133

366

2.34

16.93

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1364

11102

0.78

16.61

3.3

3.8

u/ml

98.9

56.0

1.07

1313

10701

(46235355) HIV 1 and 2 tests - Meaningful Use set

4699

26551

1.15

16.59

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

4273

31218

0.86

16.57

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

166

507

2.11

16.52

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

468

4492

0.66

16.33

1.6

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

380

1514

1.62

16.26

1.2

mmol/l

12.3

12.0

0.19

134

492

(21491868) Cryoglobulin [Mass/volume] in Serum

215

728

1.90

16.13

1.2

g/l

0.2

0.7

1.82

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1130

5540

1.32

16.12

1.4

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

242

853

1.83

16.05

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

107

274

2.51

15.89

1.7

1.3

41.3

54.9

1.99

122

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

142

414

2.20

15.86

1.2

1.4

—

(3044927) Protein electrophoresis panel - Urine

522

2249

1.50

15.84

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

353

1395

1.63

15.63

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

352

1401

1.62

15.16

1.2

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1170

0.38

15.11

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

650

2950

1.42

15.09

1.9

ug/l

22.8

25.8

0.64

636

2891

(3000494) Fungus identified in Specimen by Culture

4720

26855

1.14

15.01

1.6

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

239

859

1.79

14.92

1.6

nmol/l

24.8

6.6

0.40

204

723

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1423

11376

0.80

14.87

1.5

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

180

2127

0.54

14.87

1.4

1.3

pmol/l

77.8

91.2

0.36

701

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

132

385

2.20

14.77

3.0

2.2

—

(3014891) Appearance of Pleural fluid

243

2.54

14.63

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

132

387

2.19

14.60

1.2

mmol/l

1.5

1.8

1.36

237

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.84

14.52

14.6

8.0

e6/l

178.2

332.4

0.51

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1086

0.38

14.33

1.5

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.58

14.32

4.5

2.9

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1085

0.38

14.30

1.5

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

596

2691

1.43

14.27

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1084

0.38

14.27

1.5

1.4

—

(3016750) Collection duration of Urine

327

1300

1.62

14.19

2.3

2.2

min

499.6

496.3

0.21

243

961

(3042631) Mycobacterium sp identified in Specimen

695

3227

1.39

14.19

2.7

2.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1081

0.38

14.18

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

801

3810

1.36

14.09

3.7

3.4

1.4

1.5

0.15

624

2941

(3001893) Eosinophils/100 leukocytes in Pleural fluid

183

617

1.91

13.98

1.4

3.2

2.5

0.45

151

531

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

157

502

2.01

13.94

1.4

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1254

6358

1.27

13.92

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

144

446

2.08

13.92

1.2

1.1

umol/24h

11.0

0.7

0.52

219

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

100

265

2.42

13.90

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

308

1213

1.63

13.89

1.1

nmol/l

3.3

6.4

0.93

248

(3014148) Varicella zoster virus Ab [Titer] in Serum

492

2167

1.46

13.47

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

255

2.42

13.30

1.3

nmol/l

8.3

276311.5

1.70

211

(40762365) Oxygen content in Arterial blood by calculation

122

362

2.17

13.16

2.6

3.3

ml/dl

15.1

14.7

0.82

111

341

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

218

2.53

13.12

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

166

555

1.92

13.04

1.4

23.7

20.7

0.69

147

512

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

493

2190

1.45

12.93

3.5

3.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

937

0.37

12.77

1.6

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

575

2634

1.41

12.76

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1325

0.47

12.65

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

272

1066

1.64

12.56

1.4

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1131

5746

1.27

12.39

1.6

e6/l

14406.0

13638.4

0.21

797

4182

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

271

1066

1.64

12.35

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

144

468

1.98

12.30

1.1

—

(3045414) Leukocytes [Presence] in Urine

1851

9931

1.20

12.22

2.2

1.8

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

141

2.87

12.14

1.9

1.4

45.5

39.1

0.54

(3047352) Trisomy 18 risk [Likelihood] in Fetus

905

0.37

12.12

1.5

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

980

0.40

12.12

1.2

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

421

3887

0.69

12.09

3.6

u/ml

48.9

39.0

0.39

401

3769

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

34740

218992

1.10

12.07

5.7

4.6

mmol/l

6.3

6.0

273.76

32029

199065

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

306

1248

1.58

12.04

1.5

—

(3005033) Fetal Nuchal fold Thickness US

901

0.38

12.01

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

35006

220781

1.11

11.92

5.9

4.4

mmol/l

1.3

1.5

307.65

32944

201731

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

104

302

2.21

11.87

1.4

13.3

11.5

0.26

165

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

333

1393

1.54

11.75

1.2

u/l

102.6

88.1

1.16

288

1212

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

303

1242

1.57

11.69

1.5

—

(40768793) Breast Pathology biopsy report

569

4967

0.73

11.68

1.3

—

(4010399)

3017

16927

1.15

11.63

1.5

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

731

3538

1.33

11.55

1.6

g/l

0.8

0.04

567

2615

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

2.44

11.53

1.1

—

(40757373) Influenza virus identified in Isolate

126

400

2.02

11.51

1.4

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

445

1987

1.44

11.43

2.3

2.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

262

2.28

11.40

1.3

u/l

104.2

184.9

0.28

191

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

288

1175

1.58

11.35

1.1

u/l

50.1

22.2

3.16

204

921

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

434

1932

1.45

11.33

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2466

13664

1.17

11.21

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

707

3421

1.33

11.21

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

747

6235

0.76

11.21

1.3

iu/l

31.3

34.0

1.22

624

5369

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

267

1074

1.60

11.18

3.7

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

286

1175

1.57

10.96

1.1

u/l

121.5

81.2

3.79

217

955

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

121

2.92

10.96

2.0

1.3

14.5

12.6

0.23

(3008116) Ketones [Moles/volume] in Urine by Test strip

129

421

1.97

10.95

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

225

873

1.66

10.88

1.2

1.1

ng/l

377.7

692.3

0.54

203

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1235

6441

1.24

10.83

1.6

iu/ml

15.3

6.3

0.47

282

1384

(3000034) Microalbumin [Mass/volume] in Urine

464

2114

1.41

10.71

3.3

3.0

mg/l

73.4

40.7

1.02

342

1506

(3023383) Lactate [Moles/volume] in Pleural fluid

181

665

1.75

10.67

1.4

1.3

mmol/l

3.4

3.6

0.25

162

617

(1761482) Bacteria [#/volume] in Urine by Culture

1130

5846

1.25

10.67

4.8

4.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

320

1359

1.51

10.59

1.2

u/l

27.7

24.8

0.39

275

1155

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

602

2881

1.35

10.32

1.4

1.5

—

(4198724)

169

615

1.77

10.31

1.7

2.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

761

3778

1.30

10.09

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

261

1072

1.57

10.07

1.2

1.1

iu/ml

5.0

3.7

0.27

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

681

0.35

10.06

1.3

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

188

2.43

10.02

1.5

2.7

mmol/l

1.0

1.2

0.11

136

(3043410) Blood group antigens tested for on Red Blood Cells

155

557

1.79

9.88

1.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

146

516

1.82

9.82

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

146

516

1.82

9.82

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

146

516

1.82

9.82

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

146

516

1.82

9.82

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

35219

222582

1.10

9.78

6.0

4.4

mmol/l

4.1

4.8

307.65

33286

204525

(3042111) Morphology [Interpretation] in Bone marrow Narrative

761

3798

1.29

9.71

1.5

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

141

495

1.83

9.70

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

887

4517

1.27

9.64

1.3

1.2

u/ml

10.1

14.5

0.24

(3024522) Salmonella sp identified in Specimen by Organism specific culture

598

2892

1.33

9.60

1.4

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

195

755

1.66

9.57

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

610

2963

1.33

9.50

1.4

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

741

3700

1.29

9.44

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

509

2411

1.36

9.38

1.4

1.3

—

33.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

330

1449

1.46

9.35

1.6

1.5

u/l

7.3

6.2

0.39

158

698

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7447

44495

1.09

9.33

1.3

1.2

u/ml

1.5

1.8

0.98

1970

11634

(3025468) Yersinia sp identified in Specimen by Organism specific culture

590

2862

1.33

9.29

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

124

424

1.88

9.27

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

590

2863

1.33

9.27

1.4

1.5

—

(3020491) Glucose [Moles/volume] in Blood

347

1542

1.45

9.25

2.1

1.8

mmol/l

7.5

7.1

1.26

254

1065

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

11015

66878

1.08

9.24

4.1

22.7

21.6

9.71

5130

31645

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

200

2.31

9.21

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

590

2868

1.32

9.16

1.4

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

382

1732

1.42

9.14

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

340

1510

1.45

9.10

1.7

1.5

umol/l

69.3

71.2

0.19

117

(4146454)

544

2618

1.34

9.05

2.9

2.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

7.34

9.04

1.2

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

321

1414

1.46

8.98

1.3

titre

390.4

486.6

0.16

109

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

730

3668

1.28

8.89

1.1

1.2

—

(3008898) HLA-B27 [Presence]

771

6221

0.79

8.89

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.13

8.87

10.9

9.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

104

2.84

8.82

1.3

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

553

4635

0.76

8.67

1.5

1.4

pmol/l

225.6

158.1

1.02

542

4516

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.17

8.66

9.3

9.2

38.2

49.7

0.90

(1617658) Protocol used for examination of sentinel lymph nodes

175

1795

0.62

8.61

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

362

1645

1.42

8.59

1.6

1.5

u/ml

25.9

24.2

0.23

341

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

106

2.79

8.54

1.7

1.2

1.6

1.8

0.11

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

208

2.22

8.46

1.2

1.1

u/l

18.5

20.1

0.29

140

(3000492) Spirometry study

3648

21143

1.12

8.45

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

254

1083

1.51

8.37

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

144

534

1.73

8.34

1.5

1.4

24.7

22.8

0.32

115

451

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

698

3522

1.28

8.25

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

200

811

1.59

8.25

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

375

3296

0.73

8.20

1.1

u/ml

2.6

1.3

0.75

142

1282

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4421

25927

1.11

8.20

2.0

1.8

1.7

1.5

27.39

3766

22644

(3008757) Leukocyte morphology finding [Identifier] in Blood

528

2573

1.32

8.12

3.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

309

1380

1.44

8.10

1.3

titre

109.5

62.0

0.36

117

(3026389) Candida sp identified in Specimen by Organism specific culture

617

3073

1.29

8.09

1.4

—

(3000012) Reticulocyte production index

283

1243

1.46

8.09

1.4

1.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

555

2728

1.31

8.03

2.1

2.3

titre

8.5

7.7

0.04

100

(3019225) pH of Specimen

3970

23178

1.11

8.03

5.4

4.1

—

(40768800) Prostate Pathology biopsy report

667

5405

0.79

8.02

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

205

2.19

7.99

2.3

2.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

151

575

1.69

7.98

1.5

1.4

g/l

15.3

12.4

3.31

115

431

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

248

2.07

7.93

1.5

1.4

69.6

72.6

0.32

208

(3018851) Theophylline [Moles/volume] in Serum or Plasma

185

2.26

7.93

1.5

1.6

umol/l

44.8

45.5

0.05

185

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

185

744

1.60

7.92

2.1

1.8

e6/l

9262.5

11864.2

0.26

101

400

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

237

1010

1.51

7.87

1.1

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

299

1335

1.44

7.86

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

176

702

1.61

7.80

1.4

1.5

pmol/l

16.3

15.2

0.72

143

591

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

250

1081

1.49

7.75

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

326

1483

1.41

7.75

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.97

7.69

26.2

11.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

302

1359

1.43

7.63

1.1

—

(3003129) Base excess in Capillary blood by calculation

150

578

1.67

7.61

1.8

1.7

mmol/l

0.6

0.7

0.09

140

549

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

218

2.12

7.60

1.1

umol/24h

7.1

1.7

0.55

218

(40761536) Microorganisms panel - Urine sediment

3169

18351

1.12

7.46

5.0

4.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

285

1275

1.44

7.44

1.5

1.4

u/l

8.1

5.6

1.58

246

1071

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

202

1942

0.67

7.41

1.4

nmol/l

0.2

0.3

4.16

141

1407

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

4.35

7.36

5.0

3.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

864

4533

1.23

7.32

1.3

1.2

u/ml

2.2

6.4

2.56

343

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

213

2.11

7.31

2.3

2.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

301

1366

1.42

7.28

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

535

2657

1.30

7.23

1.3

1.2

u/ml

58.8

59.7

0.02

171

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

164

2.27

7.22

1.3

pmol/l

12.6

16.7

0.48

145

(3042010) Triglyceride [Moles/volume] in Pleural fluid

325

1.88

7.21

1.4

1.2

mmol/l

1.0

1.6

0.55

213

(3014133) Dog dander IgE Ab [Units/volume] in Serum

247

2271

0.70

7.16

1.1

u/ml

4.7

3.6

0.39

854

(3010726) Horse dander IgE Ab [Units/volume] in Serum

296

2632

0.72

7.04

1.1

u/ml

1.6

0.03

613

(3015183) Erythrocyte sedimentation rate

1047

0.56

6.96

1.5

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1496

8292

1.16

6.89

1.1

u/ml

33.0

4.5

0.67

132

(4034850)

1320

7252

1.17

6.81

14.8

9.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

181

2.16

6.81

1.2

ug/l

93.6

113.6

0.47

106

(3023487) Leukocytes [#/volume] in Peritoneal fluid

200

850

1.51

6.80

2.2

2.0

e6/l

8111.6

2157.0

0.71

143

577

(3047189) Immunofixation for 24 hour Urine

243

1075

1.45

6.78

1.6

1.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1004

5391

1.20

6.75

1.3

u/ml

7.3

5.6

0.30

113

554

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

328

1532

1.38

6.75

2.0

2.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

232

2132

0.70

6.74

1.1

u/ml

2.1

3.6

1.26

820

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

152

609

1.60

6.69

1.3

ug/l

179.1

291.5

0.55

334

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

371

1770

1.35

6.69

2.0

u/field

2.2

2.3

0.12

150

741

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1016

5468

1.20

6.67

1.3

u/ml

8.1

7.5

0.15

172

874

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

196

1853

0.68

6.65

1.0

u/ml

1.3

0.5

0.44

419

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

213

2.05

6.64

1.1

—

(3002256) Pathology report gross observation

4377

30387

0.92

6.63

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1090

5909

1.19

6.60

1.3

1.2

u/ml

48.8

34.8

0.76

343

(3017354) Segmented neutrophils/100 leukocytes in Blood

481

2388

1.30

6.57

3.5

3.4

61.6

57.9

2.83

308

1544

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

115

2.46

6.52

1.1

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

344

2951

0.75

6.51

1.0

1.1

u/ml

2.9

3.9

0.90

152

1411

(3044941) Cell count panel - Synovial fluid

711

3704

1.24

6.49

1.4

—

(3011544) Albumin [Mass/volume] in Pleural fluid

202

2.07

6.49

1.2

1.1

g/l

15.0

18.3

2.67

181

(3012565) Volume of 24 hour Urine

256

1156

1.42

6.43

2.3

2.2

1846.5

1972.3

1.17

228

1030

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

112

419

1.72

6.41

1.3

1.2

mg/l

76.0

26.6

0.40

318

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

1077

1.44

6.41

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

19271

127213

0.95

6.38

2.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

1078

1.44

6.38

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

188

802

1.51

6.32

1.1

miu/ml

1647.3

1506.3

0.86

188

802

(3033799) Differential panel - Peritoneal fluid

172

720

1.53

6.31

1.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

599

3073

1.25

6.29

1.1

g/l

1.6

1.5

3.44

541

2769

(3028192) IgG subclass 2 [Mass/volume] in Serum

454

2252

1.30

6.26

1.3

1.4

g/l

2.7

3.0

2.08

329

1523

(3027135) IgG subclass 1 [Mass/volume] in Serum

454

2254

1.30

6.22

1.3

1.4

g/l

7.1

6.8

0.77

328

1524

(3035320) C reactive protein [Mass/volume] in Body fluid

332

1576

1.35

6.22

3.0

2.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

453

2251

1.29

6.17

1.3

1.4

g/l

0.5

0.4

0.80

334

1523

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

35801

227181

1.08

6.15

6.7

4.9

mmol/l

2.2

2.9

307.65

33745

207593

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

652

3387

1.24

6.14

1.1

iu/ml

268.8

4075.2

0.62

131

690

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

264

1215

1.40

5.99

1.6

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

264

1215

1.40

5.99

1.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

264

1215

1.40

5.99

1.6

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

264

1215

1.40

5.99

1.6

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

344

1652

1.34

5.99

1.0

mg/l

295.2

468.8

0.47

310

1465

(3028433) Virus identified in Specimen by Culture

173

734

1.51

5.99

1.2

—

(4062490)

451

2250

1.29

5.98

1.3

1.4

—

(3003338) MCHC [Mass/volume]

28532

186239

0.95

5.96

29.9

17.5

g/l

331.6

332.7

62.84

28318

185014

(21494434) Karyotype in Bone marrow

409

2017

1.30

5.92

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6209

37455

1.07

5.90

1.3

iu/ml

42.2

38.7

0.63

1858

11890

(3019897) Erythrocyte distribution width [Ratio] by Automated count

282

2452

0.74

5.90

3.6

2.8

13.4

13.2

1.83

276

2419

(3032057) Clostridioides difficile [Presence] in Stool

117

454

1.66

5.90

1.6

1.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

154

2.17

5.89

3.7

5.3

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

154

2.17

5.89

1.3

1.2

24.6

19.6

0.20

(3008401) Mugwort IgE Ab [Units/volume] in Serum

334

2832

0.75

5.87

1.0

1.1

u/ml

1.0

0.05

124

1138

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

344

1.75

5.85

1.4

1.2

ng/l

91.2

129.3

0.46

226

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.36

5.84

1.3

1.5

ug/l

94.0

137.0

0.56

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

221

1.95

5.75

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.65

5.70

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

345

2898

0.76

5.68

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

345

2897

0.76

5.67

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

114

1163

0.63

5.66

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

425

0.39

5.66

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

557

2882

1.24

5.50

2.3

2.0

mg/l

25.8

26.9

0.18

144

775

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.89

5.45

1.0

—

(3044007) Cell count panel - Peritoneal fluid

159

680

1.50

5.36

2.0

1.9

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.97

5.30

4.1

3.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

279

1.80

5.28

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.62

5.27

1.0

1.1

pmol/l

156.5

206.4

0.42

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

257

1207

1.37

5.23

2.0

1.7

u/field

2.4

2.3

0.08

164

872

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

585

3062

1.23

5.21

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

179

789

1.46

5.21

1.6

1.8

u/ml

115026.3

12944.0

0.77

115

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

138

577

1.54

5.18

1.4

1.3

34.7

38.5

0.52

383

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

295

1.76

5.17

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

576

3013

1.23

5.17

1.5

1.6

61.0

57.6

1.27

379

1883

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

984

7334

0.86

5.09

1.7

1.8

nmol/l

41.0

40.8

0.12

948

7142

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

461

2359

1.26

5.05

1.7

2.0

titre

760.0

3807.0

—

138

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

321

2676

0.77

5.05

1.1

u/ml

3.3

3.4

0.08

101

1195

(4211845)

239

1117

1.37

5.03

3.5

3.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

370

1.67

5.03

2.6

mg/l

44.4

49.5

0.10

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

237

1.84

5.01

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

456

2335

1.26

4.98

1.1

iu/ml

2.1

1.9

0.10

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

628

0.53

4.98

2.0

1.8

—

(3025130) Human papilloma virus identified in Specimen

249

2145

0.74

4.97

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

784

4244

1.19

4.95

1.3

1.2

u/ml

42.7

46.4

0.28

412

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

2.11

4.94

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

175

1.98

4.92

1.1

1.0

—

(1002224) Polysomnography panel

1265

9234

0.88

4.90

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2749

19214

0.91

4.86

2.2

nmol/l

12.4

13.2

4.95

2406

17191

(44786800) Granulocytes/100 leukocytes in Body fluid

268

1.77

4.84

1.4

1.3

17.4

28.3

2.23

213

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1395

7907

1.14

4.81

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

370

1.65

4.81

1.7

1.6

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.37

4.78

1.2

1.3

g/l

0.1

0.07

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

149

1382

0.69

4.71

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

363

1.65

4.68

1.2

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

328

1631

1.29

4.58

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

901

4970

1.17

4.57

1.6

1.8

iu/l

24.7

12.6

0.36

304

1712

(3006462) Nitrate [Presence] in Urine

219

1027

1.37

4.57

3.5

3.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

145

2.04

4.54

1.1

u/l

11.5

10.5

0.13

145

(3002331) Protein [Mass/volume] in Peritoneal fluid

126

534

1.52

4.51

1.5

1.4

g/l

36.6

36.8

0.01

105

396

(3018133) Calcium [Moles/volume] in Urine

304

1.69

4.47

1.6

1.8

mmol/l

2.5

2.7

0.37

271

(3010144) Erythrocytes [#/volume] in Synovial fluid

435

2249

1.24

4.42

1.3

1.4

e6/l

152876.8

107119.4

0.57

295

1547

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

210

1.83

4.41

1.1

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

106

1035

0.66

4.41

1.0

1.1

u/ml

5.1

6.4

0.29

162

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

202

1.84

4.34

1.1

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

333

1673

1.28

4.32

1.0

ng/l

36.3

43.2

2.29

221

1190

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

332

1671

1.28

4.25

1.0

ng/l

738.9

739.8

0.01

216

1160

(3006270) Folate [Moles/volume] in Blood

355

1805

1.26

4.19

1.2

nmol/l

340.8

360.9

1.03

283

1515

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

161

728

1.42

4.19

1.1

—

(3022689) Creatine [Moles/volume] in Urine

150

670

1.44

4.17

1.6

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

437

2279

1.23

4.13

1.5

27.0

30.5

1.29

277

1396

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

361

1846

1.26

4.08

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1422

10178

0.89

4.06

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

329

1665

1.27

4.06

1.0

ng/l

292.7

344.2

1.23

225

1201

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

641

3477

1.19

4.04

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

874

0.65

4.01

1.5

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

683

0.60

3.99

1.5

1.8

—

(3021788) Differential panel - Synovial fluid

797

4412

1.16

3.93

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

521

2783

1.20

3.91

3.3

3.4

nmol/l

7.4

8.3

0.14

505

2704

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

231

1122

1.32

3.90

3.7

3.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

250

1229

1.31

3.88

1.2

u/l

213.4

371.7

2.26

234

1135

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.79

3.88

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2335

13783

1.09

3.87

1.3

au/ml

51.7

52.5

0.04

620

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

155

1.91

3.84

1.0

—

(40761511) CBC panel - Blood by Automated count

36188

230316

1.06

3.83

21.7

12.6

—

(1175426) CD3 cells/100 lymphocytes in Blood

327

1669

1.26

3.79

2.0

72.3

72.0

0.13

306

1605

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.55

3.78

2.5

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

578

4378

0.84

3.78

1.2

1.3

miu/ml

221.1

211.3

0.19

160

1840

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

193

1.80

3.78

2.3

61.6

59.3

0.17

120

(36660697) Celiac disease serology panel - Serum

2720

16182

1.08

3.75

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

2.73

3.74

1.1

mu/l

121.1

24.1

0.73

(3011412) CD3 cells [#/volume] in Blood

409

2144

1.23

3.73

2.1

2.5

e9/l

1.1

0.19

259

1283

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2552

15152

1.09

3.70

2.4

au/ml

26.7

26.5

0.02

812

(3013166) Neutrophils/100 leukocytes in Synovial fluid

156

719

1.39

3.70

1.3

1.4

63.0

54.5

2.24

127

619

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.57

3.68

1.2

1.1

mmol/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

176

1.82

3.68

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.45

3.66

1.1

—

(40768795) Lymph node Pathology biopsy report

306

2456

0.80

3.65

1.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

389

1.54

3.62

1.1

pmol/l

9.6

7.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

339

1.57

3.58

5.4

5.3

ug/min

50.3

48.5

0.09

269

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

200

965

1.33

3.57

1.7

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

200

966

1.33

3.55

1.7

2.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

119

2.00

3.54

1.4

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

202

979

1.33

3.51

1.7

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

408

1.51

3.49

1.1

—

(3002619) Bacteria identified in Specimen by Culture

105

455

1.48

3.48

1.4

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

120

1.98

3.47

1.1

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

146

674

1.39

3.46

1.2

g/l

0.3

1.28

116

548

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

162

761

1.37

3.46

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

199

1.74

3.45

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

882

0.68

3.44

1.0

u/ml

0.3

1.1

0.62

124

(3051339) Copper [Moles/volume] in Blood

103

2.06

3.42

1.1

1.2

umol/l

18.1

16.1

1.31

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

124

1115

0.71

3.41

1.4

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

130

1.93

3.40

3.9

4.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

166

1425

0.75

3.39

5.8

6.5

—

(3024869) Neuronal Ab [Presence] in Serum

103

449

1.47

3.33

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

106

465

1.46

3.33

1.1

u/ml

—

26.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

111

492

1.45

3.31

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

178

1.77

3.30

1.1

iu/ml

13.0

20.6

0.55

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.19

3.29

1.1

1.2

ng/l

6460.8

2531.3

0.72

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

155

1.82

3.27

2.0

2.3

13.3

17.5

0.45

(3028679) Herpes simplex virus Ab [Presence] in Serum

180

868

1.33

3.27

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

114

1.97

3.26

1.1

u/l

2.5

3.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

1008

0.71

3.26

1.0

u/ml

0.4

1.2

2.69

246

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

104

458

1.46

3.21

2.6

2.4

mmol/l

7.6

7.4

0.29

265

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

785

0.67

3.21

2.3

1.6

ug/l

5.0

5.9

0.17

538

(3037556) Urate [Mass/volume] in Serum or Plasma

145

678

1.37

3.21

1.6

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

175

1.76

3.20

1.9

2.4

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

316

1644

1.24

3.17

2.0

14.1

15.4

0.75

136

685

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

147

1268

0.74

3.14

14.8

17.6

nmol/l

6360.7

3403.2

0.25

139

1214

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.41

3.13

2.7

2.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

305

1583

1.24

3.13

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

305

1583

1.24

3.13

1.2

1.1

—

(4015189)

142

665

1.37

3.13

2.0

2.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1589

1.24

3.13

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1590

1.24

3.11

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

306

1591

1.24

3.09

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

423

2272

1.20

3.09

1.8

1.4

iu/ml

36.1

29.5

0.39

(3028707) Methadone [Presence] in Urine by Screen method

397

2121

1.20

3.07

2.2

2.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

304

1581

1.24

3.07

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

143

1234

0.74

3.07

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

135

630

1.38

3.05

1.2

114.3

111.9

0.56

122

562

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.83

3.02

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

203

0.38

3.01

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

314

1.53

2.98

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

143

678

1.35

2.94

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5727

35197

1.05

2.91

1.3

u/ml

16.4

13.0

1.37

2122

13255

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

245

1957

0.80

2.89

4.2

5.2

u/ml

59.2

113.9

1.41

566

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

2.89

0.0

6.0

—

0.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

143

1.80

2.88

1.1

1.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

172

842

1.31

2.86

1.6

1.5

iu/ml

2849606.7

2071109.9

0.17

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

105

939

0.72

2.86

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

231

1.61

2.85

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

187

927

1.30

2.84

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.24

2.84

1.1

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

134

635

1.36

2.79

1.7

2.1

u/l

20.2

46.0

3.15

123

573

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.81

2.79

1.3

1.4

e6/l

21.3

39.4

—

(3036603) Volume of Urine

304

1602

1.22

2.75

1.6

1812.7

1961.7

0.84

366

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

142

1204

0.76

2.74

10.3

12.6

nmol/l

835.9

1676.7

0.51

137

1156

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

107

490

1.40

2.74

1.1

—

(3022229) Phosphate [Moles/volume] in Urine

2.08

2.74

1.6

1.5

mmol/l

13.8

17.1

0.66

(3034274) Bile acid [Moles/volume] in Serum --fasting

227

1161

1.26

2.71

1.3

1.7

umol/l

11.5

11.8

0.04

158

845

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

142

1.76

2.67

1.5

1.3

—

(3027944) Amphetamines [Presence] in Urine

668

4859

0.88

2.64

1.9

—

(3012898) Urea [Moles/volume] in Urine

211

1.61

2.64

1.5

1.4

mmol/l

131.6

188.5

3.31

191

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

155

759

1.31

2.61

2.2

1.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

282

1484

1.22

2.61

1.8

2.7

e6/l

629.0

527.7

0.34

228

1257

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

258

1346

1.23

2.60

2.2

2.9

37.2

38.1

0.27

102

423

(3009871) Measles virus Ab [Titer] in Serum

150

732

1.32

2.59

1.5

1.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

330

1.48

2.59

1.9

2.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

179

0.39

2.57

3.5

7.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

37032

238922

0.95

2.55

14.0

10.4

u/l

28.4

26.8

12.52

36055

230003

(3001964) Herpes simplex virus Ag [Presence] in Specimen

135

651

1.33

2.54

1.5

1.6

—

(4281824)

333

2543

0.84

2.54

1.2

1.1

—

(3024263) Appearance of Synovial fluid

239

1241

1.24

2.53

1.4

1.7

—

(3027008) Opiates [Presence] in Urine

684

4950

0.88

2.51

1.9

—

(44806420)

133

642

1.33

2.50

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

929

5374

1.11

2.47

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.85

2.46

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

113

1.82

2.44

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

296

1578

1.20

2.43

1.8

2.1

nmol/l

15.7

16.9

2.01

271

1477

(3000285) Sodium [Moles/volume] in Blood

288

1.49

2.42

1.1

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.61

2.41

1.1

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.00

2.40

1.0

1.1

mmol/l

5.7

5.2

0.26

(3028300) Cannabinoids [Presence] in Urine

689

4966

0.89

2.39

1.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

119

1.78

2.36

2.0

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

116

554

1.34

2.36

1.1

1.2

pmol/l

335.4

287.3

0.33

401

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.18

2.34

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

149

739

1.29

2.33

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

291

2229

0.84

2.33

1.3

1.4

u/l

36.0

33.0

0.73

233

1804

(3036670) Protein [Mass/volume] in Synovial fluid

146

725

1.29

2.27

1.1

1.3

g/l

40.3

40.1

0.06

392

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

33509

213412

1.04

2.26

20.8

12.8

ml/min/173m2

76.5

79.8

138.82

29167

175593

(3005082) Progesterone [Moles/volume] in Serum or Plasma

263

0.54

2.24

1.2

1.3

nmol/l

18.9

28.6

1.30

223

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

263

0.54

2.24

1.2

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

246

0.52

2.24

2.8

3.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

191

984

1.25

2.22

1.4

1.5

umol/l

17.1

25.9

5.50

182

928

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

245

0.52

2.21

5.7

6.0

—

(3008896) Cortisol [Moles/volume] in Urine

6.42

2.21

1.2

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

166

1.62

2.20

1.1

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

149

746

1.28

2.19

1.8

2.1

12.1

10.3

0.74

130

688

(3041806) Other cells [#/volume] in Blood by Manual count

175

0.44

2.19

1.9

1.6

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.53

2.18

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

150

754

1.28

2.15

1.7

2.1

29.8

0.01

139

709

(3000764) Benzodiazepines [Presence] in Urine

687

4917

0.89

2.15

1.9

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.92

2.14

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

390

2157

1.16

2.14

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

153

1.64

2.11

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1551

9262

1.08

2.09

1.3

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

4075

25054

1.05

2.08

2.1

2.3

ug/g

179.4

137.4

5.35

3256

19651

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

477

0.67

2.06

1.0

u/ml

7.6

10.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4118

25350

1.05

2.01

3.5

4.2

ug/l

16.9

27.2

2.02

3399

20600

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.28

2.00

1.5

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

569

3247

1.13

2.00

2.5

2.6

u/ml

143.0

927.4

1.47

561

3180

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

520

1.32

1.99

2.3

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

495

0.69

1.97

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

100

483

1.33

1.95

1.3

1.2

umol/l

16.8

16.7

0.09

429

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

172

1.57

1.94

1.5

2.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

124

1015

0.78

1.94

1.0

1.1

u/ml

0.5

1.7

2.15

296

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

137

1.64

1.94

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

573

1.30

1.93

1.2

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.80

1.91

1.1

u/l

221.1

346.9

1.50

(3010503) CD19 cells [#/volume] in Blood

263

1425

1.19

1.90

2.2

2.7

e9/l

0.1

0.4

2.10

251

1386

(3029075) Extractable nuclear Ab panel - Serum

124

620

1.28

1.89

1.1

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

348

1.38

1.89

1.7

pmol/l

93.1

48.4

1.10

289

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

2.06

1.87

1.6

1.4

0.7

0.5

0.27

(3016228) CD19 cells/100 cells in Blood

180

942

1.23

1.87

2.3

2.0

7.0

8.4

0.86

171

922

(3007916) DNA double strand Ab [Titer] in Serum

279

1.43

1.86

1.5

1.2

titre

78.6

208.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

263

1428

1.18

1.86

1.9

2.8

e9/l

0.2

0.44

230

1248

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

124

1.66

1.85

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

156

805

1.24

1.85

1.1

—

(3049233) Organic acids panel - Urine

3.85

1.84

1.0

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

2120

12858

1.06

1.84

1.4

1.3

u/ml

233.3

249.9

0.33

1953

11894

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.75

1.84

1.1

1.0

—

(4024509)

395

2216

1.15

1.83

1.7

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

818

4788

1.10

1.82

4.1

3.3

mg/l

28.4

26.7

0.57

517

3019

(3016879) Cocaine [Presence] in Urine

652

4629

0.90

1.81

1.9

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

2.02

1.79

1.4

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

320

1772

1.16

1.79

1.2

u/ml

67.1

81.2

0.29

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

321

1778

1.16

1.79

1.2

u/ml

36.0

45.2

0.35

132

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.74

1.78

1.5

1.6

u/l

0.0

0.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

876

5151

1.09

1.78

2.9

3.5

u/ml

1740.6

656.7

0.72

793

4687

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1467

8805

1.07

1.77

3.0

3.6

u/ml

2660.4

1190.1

0.37

1244

7570

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

306

1690

1.16

1.77

1.2

u/ml

10.8

7.8

0.12

114

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

424

2398

1.14

1.76

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

304

1.39

1.76

1.8

2.0

umol/l

19.0

17.3

0.48

304

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

125

634

1.27

1.73

1.6

ug/l

9.9

9.1

1.18

125

634

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

305

1.39

1.73

1.3

1.2

—

(3022145) Colonoscopy Study observation

4300

26592

1.04

1.73

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

394

1.34

1.70

5.5

6.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.39

1.69

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

477

2727

1.12

1.68

1.3

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

184

1.50

1.68

1.3

ml/s/173m2

1.0

1.2

0.29

117

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.82

1.68

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

327

1824

1.15

1.68

1.2

u/ml

35.7

56.9

0.69

(3019420) Tryptase [Mass/volume] in Serum or Plasma

197

1054

1.20

1.68

1.3

1.6

ug/l

9.9

8.7

0.22

179

964

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

4.01

1.65

1.2

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

4.01

1.65

1.2

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

486

1.29

1.64

1.2

1.3

mu/l

160.3

58.6

0.73

349

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

403

1.32

1.62

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

165

1.52

1.62

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.82

1.53

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

480

1.28

1.53

1.4

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

310

0.66

1.51

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.56

1.51

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.09

1.50

1.1

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

1.90

1.47

1.7

1.5

nmol/l

127.5

217.7

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

2.96

1.47

1.2

1.1

umol/l

60.1

73.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

164

1.49

1.46

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

250

1.39

1.45

4.0

2.7

mg/l

1.3

1.2

0.18

178

(3009015) Lactate [Moles/volume] in Synovial fluid

268

1.37

1.40

1.1

1.3

mmol/l

6.3

6.2

0.08

130

(40765089) Chromosome analysis panel - Blood by G-banded

266

0.65

1.40

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.66

1.39

10.3

8.4

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

1.39

0.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

273

0.66

1.38

1.6

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

202

0.60

1.37

1.8

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

303

0.68

1.37

1.1

1.0

ug/l

106.1

84.9

1.43

236

(40759632) Porphyrins [Mass/mass] in Stool

2.75

1.36

1.0

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

120

1.55

1.36

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

171

925

1.19

1.35

2.3

2.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

147

1128

0.84

1.35

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.64

1.34

1.0

u/ml

0.0

0.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

157

1.47

1.34

1.1

1.3

mg/l

53.1

49.1

0.15

(3022475) Manganese [Moles/volume] in Blood

135

0.52

1.33

1.5

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

211

1.40

1.32

1.3

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

169

1.44

1.29

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

223

1.38

1.29

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

111

579

1.23

1.29

1.6

1.5

ug/l

0.4

0.17

382

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

966

6623

0.93

1.27

1.9

1.7

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.57

1.27

1.0

1.1

umol/l

24.2

33.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.69

1.25

1.1

nmol/l

247.1

261.6

0.20

(3026470) Cobalt [Mass/volume] in Blood

278

1573

1.13

1.25

1.9

2.0

ug/l

4.9

3.7

0.95

241

1382

(3025577) Chromium [Mass/volume] in Blood

270

1525

1.14

1.24

2.0

2.1

ug/l

2.8

2.3

0.67

224

1272

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

331

1895

1.12

1.23

2.0

1.9

mg/l

4.5

3.8

1.99

312

1813

(3003327) Ova and parasites identified in Stool by Light microscopy

1139

6883

1.06

1.22

1.6

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

250

1822

0.88

1.21

1.2

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

1.20

0.0

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

785

5407

0.93

1.20

1.8

1.9

pmol/l

193.7

203.9

2.04

738

5140

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4667

29134

1.03

1.18

5.6

4.5

33.2

31.8

15.31

3733

18889

(42870560) Thyrotropin [Units/volume] in Cord blood

0.43

1.16

1.0

mu/l

8.0

7.7

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

157

1.43

1.16

1.7

1.2

mmol/l

25.2

21.1

2.82

117

(3038177) Helicobacter pylori Ab [Presence] in Serum

485

3401

0.91

1.16

1.3

1.2

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

174

1.40

1.14

1.1

1.0

u/ml

6.0

5.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.55

1.12

1.0

u/ml

1.3

0.3

0.52

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.57

1.12

1.9

1.5

ug/g

188.3

183.5

0.03

(3001729) Color of Synovial fluid

186

1.38

1.10

1.3

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

203

1138

1.15

1.08

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

441

0.77

1.08

1.9

2.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

125

0.56

1.07

1.2

1.3

1.4

0.43

125

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.65

1.06

1.4

1.5

nmol/l

338.1

539.9

1.32

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

227

1.33

1.04

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

178

0.65

1.01

1.2

1.5

umol/l

0.1

0.2

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

1.01

0.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

172

1265

0.87

1.00

4.5

5.9

u/ml

398.1

3279.3

0.60

259

(3035611) Eosinophils/100 leukocytes in Synovial fluid

157

1.39

1.00

1.3

1.8

1.0

0.7

0.34

124

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

109

587

1.19

0.98

1.4

1.3

nmol/l

130.3

129.4

0.02

415

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

109

1.47

0.98

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

209

1184

1.13

0.98

1.5

3.8

3.7

0.00

256

(3030313) Adrenal Ab [Titer] in Serum

120

1.44

0.97

1.1

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

167

933

1.15

0.97

2.7

2.1

ug/l

23.1

292.9

1.60

158

888

(3013862) HLA-DP [Type]

0.55

0.96

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

219

1247

1.13

0.96

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

126

1.43

0.95

1.6

1.5

mg/l

0.8

2.3

2.09

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.95

0.95

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

100

1.48

0.93

1.0

u/ml

0.0

0.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

387

1.23

0.91

2.6

3.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

100

0.58

0.91

1.2

mg/l

1.3

1.8

—

(3001556) Androgen free Index in Serum or Plasma

100

0.58

0.91

1.0

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.53

0.90

1.0

1.1

—

(3013762) Body weight Measured

0.53

0.90

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

267

1.27

0.90

1.6

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1919

12773

0.96

0.90

1.2

iu/ml

124.8

143.3

1.13

667

4759

(3020650) Glucose [Presence] in Urine

561

0.82

0.87

1.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

167

1.34

0.87

2.0

3.2

pmol/l

14.3

461.1

0.58

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

332

1.24

0.86

1.6

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

2.03

0.86

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.60

0.86

1.1

1.3

—

(40763590) HLA-DQ beta [Type]

0.57

0.86

1.0

—

(40760410) HLA-B [Type] by High resolution

0.56

0.85

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.56

0.85

1.0

—

(40760409) HLA-A [Type] by High resolution

0.56

0.85

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7532

49128

0.98

0.85

2.8

2.9

ug/l

0.7

0.8

0.42

5139

31592

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

135

1.38

0.84

1.2

1.4

pmol/l

17.1

18.1

0.12

113

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

441

2625

1.08

0.82

2.0

2.1

u/l

3380.2

3509.5

0.03

125

927

(3021162) Amylase [Enzymatic activity/volume] in Specimen

422

1.20

0.82

2.9

2.7

u/l

1821.9

1656.9

0.06

371

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.82

0.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

370

1.21

0.81

1.4

1.3

—

(3006598) pH of Arterial cord blood

0.51

0.80

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

142

1.36

0.80

1.3

1.1

—

(4035726)

3268

21507

0.97

0.79

1.5

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

428

0.81

0.79

1.3

1.4

mmol/l

10.0

8.4

1.65

240

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

232

1644

0.90

0.78

1.7

1.6

—

(3007463) Buprenorphine [Presence] in Urine

1.70

0.76

2.1

8.4

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.14

0.75

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

180

1289

0.90

0.75

1.4

—

(3045142) Bone marrow Pathology biopsy report

448

2681

1.07

0.75

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

246

1439

1.10

0.72

1.3

g/l

1.4

1.5

0.87

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

4.3

3.7

0.18

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

0.6

1.1

0.68

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

2.6

2.7

0.04

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

1.1

2.4

1.11

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

1.8

2.1

0.06

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

2.4

2.8

0.16

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

1.7

3.1

1.09

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

1.2

2.1

1.07

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

123

1.36

0.71

1.6

1.5

mg/l

1.1

1.3

0.12

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

608

0.85

0.69

1.3

—

(3011288) Drugs identified in Urine by Screen method

464

3171

0.94

0.68

3.4

2.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

936

5746

1.05

0.67

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

270

0.78

0.67

1.6

2.1

mmol/l

8.9

7.1

1.59

107

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.60

0.65

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

123

0.68

0.65

1.1

u/ml

0.4

0.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.45

0.63

3.6

3.3

26.8

17.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

176

1022

1.11

0.63

1.2

1.3

mmol/l

6.0

0.06

158

967

(36304079) Mucus [Presence] in Urine sediment

0.00

0.62

0.0

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.62

0.0

1.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

175

1017

1.10

0.62

2.5

3.3

mu/l

22.9

27.4

1.08

162

953

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.51

0.58

2.1

2.4

mu/l

1.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

235

0.79

0.57

1.1

u/ml

0.0

0.5

1.50

151

(3033942) Copper [Moles/time] in 24 hour Urine

1.41

0.56

1.6

1.0

umol/24h

1.6

0.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.60

0.55

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

169

0.76

0.54

1.1

1.0

—

(3048879) Bone marrow aspiration report

126

727

1.11

0.53

1.5

1.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.34

0.53

1.2

1.8

nmol/l

5.1

8.7

0.37

(3045424) Erythrocytes [Presence] in Urine

641

3933

1.05

0.52

1.6

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

323

0.83

0.52

1.7

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

1.50

0.52

1.0

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

124

0.72

0.51

1.1

1.0

mmol/l

9.0

8.6

0.29

124

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.39

0.51

1.1

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

229

1364

1.08

0.50

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

435

2941

0.95

0.50

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

314

1.16

0.49

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

194

0.79

0.48

2.6

2.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

230

1374

1.07

0.48

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

285

1.17

0.48

2.5

2.4

u/field

0.5

0.6

0.25

285

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

315

1.16

0.47

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

315

1.16

0.47

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

654

0.89

0.47

2.0

1.8

mg/l

7.4

9.3

2.76

524

(3032352) Blasts [#/volume] in Cerebral spinal fluid

238

1.19

0.47

2.7

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

367

2229

1.06

0.47

1.4

1.3

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

139

815

1.09

0.46

1.4

1.7

umol/l

2.1

2.0

0.51

132

759

(40762814) Titanium [Mass/volume] in Blood

469

0.88

0.46

2.2

2.3

ug/l

3.1

3.8

1.19

166

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.40

0.45

1.1

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.69

0.44

1.6

1.5

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.60

0.43

7.0

2.3

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

141

0.77

0.43

1.0

1.4

—

17202.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

129

1.24

0.42

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

170

1.21

0.42

2.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

301

1.15

0.42

1.4

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1510

9457

1.03

0.42

1.5

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

124

1.24

0.40

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

436

2676

1.05

0.40

1.3

1.2

mmol/l

7.7

7.4

0.71

323

1940

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

276

1675

1.06

0.39

1.9

2.7

e6/l

1079.0

632.5

0.52

111

680

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

691

0.91

0.39

1.1

1.3

umol/l

2.2

3.4

5.56

634

(3036071) Salmonella sp Ab [Titer] in Serum

644

0.91

0.39

1.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.39

0.38

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

831

5496

0.97

0.38

1.1

u/ml

11.0

6.8

0.54

629

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

103

723

0.91

0.38

2.6

2.5

nmol/l

138.3

155.5

0.96

626

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.31

0.37

1.0

1.1

2.6

2.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

145

0.80

0.37

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.38

0.37

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

102

0.75

0.37

1.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.48

0.36

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

186

1272

0.94

0.36

1.0

1.1

iu/ml

11.3

8.8

0.50

295

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

115

681

1.08

0.34

2.2

2.3

ug/l

1.3

1.0

0.99

110

638

(3017732) Neutrophils [#/volume] in Blood

2397

15628

0.98

0.34

3.2

2.9

e9/l

4.4

4.0

8.58

1789

11833

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

225

0.86

0.32

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.25

0.32

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

188

1.16

0.32

1.1

1.3

nmol/l

0.1

0.2

0.88

120

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

127

0.81

0.30

1.0

u/ml

0.2

0.1

—

(40758292) HTLV I+II Ab panel - Serum

386

0.90

0.30

1.4

1.5

—

(3018291) Platelet Ab [Presence] in Serum

1.25

0.29

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

214

1.14

0.29

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

467

3097

0.97

0.29

1.1

au/ml

13.1

12.5

0.06

167

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

153

0.84

0.28

1.1

1.2

nmol/l

15.6

14.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

203

1.14

0.27

1.1

—

(40758358) Immune stain study

104

0.80

0.27

1.0

—

(3034614) HLA Ag [Interpretation]

1.22

0.27

1.4

1.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

143

1.17

0.27

1.2

1.1

u/field

1.3

1.1

0.26

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.67

0.26

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

324

2003

1.04

0.26

2.1

2.2

43.2

38.1

1.30

252

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

212

0.88

0.24

1.1

u/ml

0.0

1.7

0.84

160

(40768443) Skin Pathology biopsy report

1640

10365

1.02

0.24

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

101

607

1.07

0.24

1.3

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.34

0.23

5.2

3.7

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.28

0.23

1.2

1.4

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.22

0.0

1.3

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.24

0.22

1.0

—

(40768441) Liver Pathology biopsy report

279

1728

1.04

0.22

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

569

3739

0.98

0.22

1.9

2.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.22

0.0

1.6

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.22

0.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.21

0.21

1.1

1.0

u/ml

0.3

0.6

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.24

0.20

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.26

0.20

1.2

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1438

9102

1.01

0.20

1.1

titre

266.3

222.6

0.24

242

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

107

650

1.06

0.20

2.9

3.1

mg/l

6.0

8.0

3.28

524

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

176

1084

1.04

0.19

12.8

12.6

mmol/l

0.6

0.16

165

987

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

394

0.93

0.19

3.0

3.1

ng/l

83.7

126.8

0.97

142

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

602

1.06

0.18

2.5

2.6

au/ml

154.0

169.6

0.13

(3020123) Porphyrins [Interpretation] in Serum or Plasma

118

1.14

0.18

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

309

1.08

0.18

8.8

7.9

umol/l

0.4

0.3

1.08

283

(3034092) Cytoplasmic Ig cells/100 cells in Blood

273

0.92

0.17

11.7

8.8

—

(3042517) Benzodiazepines panel - Urine

149

1.12

0.17

1.7

2.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.12

0.17

2.0

1.4

mmol/24h

1.8

2.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

464

0.94

0.17

3.0

5.1

u/l

68.6

50.5

0.39

178

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

267

1.08

0.16

1.1

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

107

1.14

0.16

1.2

1.5

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

422

0.94

0.15

1.8

1.7

ug/l

2.0

2.3

0.65

250

(3018001) Oat IgE Ab [Units/volume] in Serum

117

0.88

0.15

1.1

1.0

u/ml

0.1

0.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

319

1.07

0.14

2.7

2.6

pmol/l

71.2

71.7

0.01

281

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

110

0.87

0.14

1.1

1.0

u/ml

0.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.84

0.14

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

295

0.94

0.13

1.0

—

(3017509) Phencyclidine [Presence] in Urine

171

1.09

0.12

1.9

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2293

14817

0.99

0.12

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

122

0.89

0.12

1.1

1.0

u/ml

0.0

0.2

0.95

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

471

2973

1.02

0.12

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

0.91

0.12

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

240

1575

0.98

0.11

1.4

1.3

u/ml

1.4

1.5

0.05

129

761

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

463

0.96

0.11

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

505

1.04

0.11

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

123

1.10

0.10

1.3

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

527

0.96

0.10

1.7

1.6

au/ml

121.7

78.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

909

5775

1.01

0.10

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

140

0.92

0.10

1.5

1.4

umol/24h

296.8

348.5

0.63

140

(3029396) Erythrocyte agglutination [Presence] in Blood

161

1.08

0.09

1.7

2.5

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.03

0.09

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

124

1.09

0.09

1.3

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

738

4780

0.99

0.08

1.9

1.7

mu/l

308.2

294.7

0.42

681

4401

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

115

718

1.03

0.08

2.1

3.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.04

0.08

1.2

1.1

—

(36303858) Crystals [Presence] in Urine

0.80

0.08

1.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.11

0.08

1.1

1.7

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

119

0.92

0.08

1.1

1.0

u/ml

0.0

0.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

158

0.93

0.07

1.5

1.6

umol/l

0.7

0.02

117

(3000060) B lymphocytes [#/volume] in Blood

536

1.03

0.07

1.9

2.1

e6/l

446.5

1248.3

0.74

283

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.09

0.07

1.4

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

164

1.06

0.06

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

234

1.04

0.05

1.1

1.3

u/ml

0.1

3.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.90

0.05

1.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.08

0.05

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

116

0.94

0.04

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

304

0.97

0.04

1.3

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

529

1.02

0.04

1.1

1.2

titre

568.0

601.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.07

0.04

1.2

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

174

0.96

0.03

1.6

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

217

1.03

0.03

1.3

2.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

211

1.03

0.03

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

103

1.06

0.03

1.0

1.1

u/ml

27.9

26.9

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

103

1.06

0.03

1.0

1.1

u/ml

55.7

25.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

191

1214

1.01

0.03

1.6

mmol/24h

5.7

0.00

(3035933) Granulocytes/100 leukocytes in Blood

519

1.01

0.02

2.2

1.6

—

(40765096) Chromosome analysis panel by Banding

111

705

1.01

0.02

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

219

1.03

0.02

5.8

5.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

768

4939

1.00

0.01

1.4

u/l

10.7

10.1

0.50

622

4024

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

249

0.98

0.01

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

512

0.99

0.01

1.6

2.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.96

0.01

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

260

1673

1.00

0.00

1.7

—

(3049242) von Willebrand panel - Platelet poor plasma

1.01

0.00

2.2

1.6

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

1.1

u/ml

0.3

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

119

1.02

0.00

1.1

1.2

—

(4133840)

103

661

1.00

0.00

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.03

0.00

1.1

u/field

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

515

1.00

0.00

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.97

0.00

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

324

1.01

0.00

1.1

1.2

—

(4212803)

224

1.00

0.00

1.1

—

(4038314)

1.00

0.00

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

626

1.00

0.00

1.1

—

(44813793)

227

1454

1.00

0.00

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.97

0.00

1.5

1.4

nmol/l

1077.3

811.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

456

1.00

0.00

1.1

u/ml

0.3

8.8

0.56

237

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.99

0.00

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.94

0.00

1.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.01

0.00

1.0

1.1

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.89

0.00

1.6

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.87

0.00

1.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.0

—

64.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CVD_HARD and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_CVD_HARD	2.022 [1.87, 2.18]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 103114 out of 212867 females with I9_CVD_HARD died.

Males

Parameter	HR [95% CI]	p-value
I9_CVD_HARD	1.77 [1.64, 1.91]	< 0.001
Birth year	0.98 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 104217 out of 262916 males with I9_CVD_HARD died.

Mortality risk

Mortality risk for people of age

years, who have I9_CVD_HARD.

N-year risk	Females	Males
1	0.112%	0.239%
5	0.763%	1.339%
10	1.972%	3.121%
15	3.597%	5.851%
20	6.203%	9.806%

Relationships between endpoints

↥

Index endpoint: I9_CVD_HARD – Hard cardiovascular diseases

GWS hits: 78

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hard cardiovascular diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints